"X."	"tissue_type"	"response_component_original"	"response_comp_orig_cnt"	"response_component"	"response_comp_cnt"	"cell_ontology_id"	"pro_ontology_id"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"baseline_time"	"target_pathogen"	"vaccine_year"	"exposure_material_text"	"exposure_material"	"additional_exposure_material"	"comparison"	"cohort"	"adjuvant"	"route"	"publication_reference"	"publication_year"	"signature_source"	"signature_source_url"	"comments"	"short_comment"	"publication_reference_url"	"age_group"	"age_min"	"age_max"	"age_units"	"subm_obs_id"	"uniq_obs_id"	"row_key"
"subject"	"cell_subset"	""	""	"cell_subset"	""	""	""	""	""	""	""	""	""	"pathogen"	""	""	"vaccine"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"evidence"	""	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	"label"	"label"	"label"	"label"	"label"
"role"	"tissue"	"observed"	"observed"	"cell_biomarker"	"observed"	"observed"	"observed"	"background"	"measured"	"background"	"observed"	"observed"	"background"	"pathogen"	"background"	"background"	"vaccine"	"background"	"background"	"observed"	"background"	"background"	"background"	"background"	"background"	"background"	"background"	"background"	"reference"	"observed"	"observed"	"observed"	"observed"	"background"	"background"	"background"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	"tissue type"	"response component (original cell type)"	"response component (original) count"	"response component (cell subset)"	"response component count"	"cell ontology ID"	"protein ontology ID"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"baseline time"	"target pathogen"	"vaccine year"	"exposure material (name)"	"exposure material (VO)"	"additional exposure material"	"comparison"	"cohort"	"adjuvant"	"route"	"publication reference (PMID)"	"publication year"	"signature source figure, table or text section"	"signature source url"	"comments and additional details"	"short comment for mSigDB standard name"	"publication url"	"cohort"	"min. age"	"max. age"	"age units"	"ID of observation within its own submission"	"Uniq ID of observation within its submission type"	"row key"
""	"blood"	"antibody secreting cell"	"1"	"antibody secreting cell"	"1"	"CL_0000946"	""	"cell type frequency"	"up"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"neisseria meningitidis"	""	"Menactra; Menomune"	"VO_0000071; VO_0000072"	""	"Menactra vs Menomune"	"adults (18-45)"	""	""	"24336226"	"2014"	"Fig 1F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226"	"adults"	"18"	"45"	"years"	"1"	"8"	"24336226_1_8"
""	"blood"	"antibody secreting cell"	"1"	"antibody secreting cell"	"1"	"CL_0000946"	""	"cell type frequency"	"up"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"neisseria meningitidis"	""	"Menactra"	"VO_0000071"	""	"d7 vs d0"	"adults (18-45)"	""	""	"24336226"	"2014"	"Fig 1F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226"	"adults"	"18"	"45"	"years"	"2"	"9"	"24336226_2_9"
""	"blood"	"antibody secreting cell"	"1"	"antibody secreting cell"	"1"	"CL_0000946"	""	"cell type frequency"	"up"	"none"	"30"	"Days"	"time of vaccination (first dose)"	"neisseria meningitidis"	""	"Menactra"	"VO_0000071"	""	"d30 vs d0"	"adults (18-45)"	""	""	"24336226"	"2014"	"Fig 1F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226"	"adults"	"18"	"45"	"years"	"3"	"10"	"24336226_3_10"
""	"blood"	"antibody secreting cell"	"1"	"antibody secreting cell"	"1"	"CL_0000946"	""	"cell type frequency"	"up"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"neisseria meningitidis"	""	"Menomune"	"VO_0000072"	""	"d7 vs d0"	"adults (18-45)"	""	""	"24336226"	"2014"	"Fig 1F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226"	"adults"	"18"	"45"	"years"	"4"	"11"	"24336226_4_11"
""	"blood"	"antibody secreting cell"	"1"	"antibody secreting cell"	"1"	"CL_0000946"	""	"cell type frequency"	"positive"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"neisseria meningitidis"	""	"Menactra"	"VO_0000071"	""	"correlated with d7 serum anti-DT IgG"	"adults (18-45)"	""	""	"24336226"	"2014"	"Fig 1G"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226"	"adults"	"18"	"45"	"years"	"5"	"12"	"24336226_5_12"
""	"peripheral blood mononuclear cell"	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell"	"2"	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell"	"2"	"CL_0000904"	""	"cell type frequency"	"negative"	"none"	"0"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	"Fluzone"	"VO_0000047"	""	"predictive of d28 HAI"	"adults"	""	""	"23591775"	"2013"	"Fig 5"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/figure/f5/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775"	"adults"	""	""	""	"1"	"13"	"23591775_1_13"
""	"peripheral blood mononuclear cell"	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell; CD8-positive, CD28-negative, alpha-beta regulatory T cell; natural killer cell"	"4"	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell; CD8-positive, CD28-negative, alpha-beta regulatory T cell; natural killer cell"	"4"	"CL_0000904"	""	"cell type frequency"	"negative"	"good responders"	"0"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	"Fluzone"	"VO_0000047"	""	"predictive of d28 HAI"	"adults"	""	""	"23591775"	"2013"	"Suppl Fig 3"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/#S1"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775"	"adults"	""	""	""	"2"	"14"	"23591775_2_14"
""	"peripheral blood mononuclear cell"	"naive thymus-derived CD8-positive, alpha-beta T cell"	"1"	"naive thymus-derived CD8-positive, alpha-beta T cell"	"1"	"CL_0000900"	""	"cell type frequency"	"positive"	"good responders"	"0"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	"Fluzone"	"VO_0000047"	""	"predictive of d28 HAI"	"adults"	""	""	"23591775"	"2013"	"Suppl Fig 3"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/#S1"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775"	"adults"	""	""	""	"3"	"15"	"23591775_3_15"
""	"peripheral blood mononuclear cell"	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell"	"2"	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell"	"2"	"CL_0000904"	""	"cell type frequency"	"negative"	"none"	"28"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	"Fluzone"	"VO_0000047"	""	"predictive of d28 HAI"	"adults"	""	""	"23591775"	"2013"	"Fig 5"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/figure/f5/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775"	"adults"	""	""	""	"4"	"16"	"23591775_4_16"
""	"peripheral blood mononuclear cell"	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell; CD8-positive, CD28-negative, alpha-beta regulatory T cell; natural killer cell"	"4"	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell; CD8-positive, CD28-negative, alpha-beta regulatory T cell; natural killer cell"	"4"	"CL_0000904"	""	"cell type frequency"	"negative"	"none"	"28"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	"Fluzone"	"VO_0000047"	""	"predictive of d28 HAI"	"adults"	""	""	"23591775"	"2013"	"Fig 7"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/figure/f7/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775"	"adults"	""	""	""	"5"	"17"	"23591775_5_17"
""	"peripheral blood mononuclear cell"	"naive thymus-derived CD8-positive, alpha-beta T cell"	"1"	"naive thymus-derived CD8-positive, alpha-beta T cell"	"1"	"CL_0000900"	""	"cell type frequency"	"positive"	"none"	"28"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	"Fluzone"	"VO_0000047"	""	"predictive of d28 HAI"	"adults"	""	""	"23591775"	"2013"	"Fig 7"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/figure/f7/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775"	"adults"	""	""	""	"6"	"18"	"23591775_6_18"
""	"blood"	"plasmablast"	"1"	"plasmablast"	"1"	"CL_0000980"	""	"cell type frequency"	"up"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"streptococcus pneumoniae"	""	"Pneumovax 23"	"VO_0000088"	""	"7d vs 0d"	"adults (18-64)"	""	""	"23601689"	"2013"	"Fig 6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681204/figure/F6/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23601689"	"adults, seniors"	"18"	"64"	"years"	"1"	"19"	"23601689_1_19"
""	"blood"	"plasmablast"	"1"	"plasmablast"	"1"	"CL_0000980"	""	"cell type frequency"	"up"	"none"	"10"	"Days"	"time of vaccination (first dose)"	"streptococcus pneumoniae"	""	"Pneumovax 23"	"VO_0000088"	""	"10d vs 0d"	"adults (18-64)"	""	""	"23601689"	"2013"	"Fig 6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681204/figure/F6/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23601689"	"adults, seniors"	"18"	"64"	"years"	"2"	"20"	"23601689_2_20"
""	"blood"	"plasmablast"	"1"	"plasmablast"	"1"	"CL_0000980"	""	"cell type frequency"	"up"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2009"	"Fluzone"	"VO_0000047"	""	"7d vs 0d"	"adults (18-64)"	""	""	"23601689"	"2013"	"Fig 6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681204/figure/F6/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23601689"	"adults, seniors"	"18"	"64"	"years"	"3"	"21"	"23601689_3_21"
""	"peripheral blood mononuclear cell"	"CD56-bright natural killer (NK) cells"	"1"	"natural killer cell & CD56-bright"	"1"	"CL_0000623"	"PR:000001024"	"cell type frequency"	"positive"	"none"	"3"	"Days"	"time of vaccination (first dose)"	"ebola virus"	""	"rVSV-EBOV"	"VO_0004660"	""	"positively correlated with antibody response at 28d & onward. "	"adults (18-55)"	""	""	"28854372"	"2017"	"Fig 4"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/figure/fig4/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/"	"adults"	"18"	"55"	"years"	"1"	"22"	"28854372_1_22"
""	"peripheral blood mononuclear cell"	"switched IgG+ memory B cells (CD3-, CD19+, HLADR+, CD27+, IgG+); IgG+ memory B cells (CD3-, CD19+, HLADR+, CD27+, CD10-, CD20+, IgG+)"	"2"	"IgG memory B cell & CD3-, CD19+, CD27+, HLADR+, IgG+; IgG memory B cell & CD3-, CD19+, CD27+, CD10-, CD20+, HLADR+, IgG+"	"2"	"CL_0000979"	"PR:000001020, PR_000001002, PR:000001963"	"cell type frequency"	"negative"	"none"	"3"	"Days"	"time of vaccination (first dose)"	"ebola virus"	""	"rVSV-EBOV"	"VO_0004660"	""	"positively correlated with antibody response at 28d & onward. "	"adults (18-55)"	""	""	"28854372"	"2017"	"Fig 4"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/figure/fig4/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/"	"adults"	"18"	"55"	"years"	"2"	"23"	"28854372_2_23"
""	"peripheral blood mononuclear cell"	"CD86+ myeloid dendritic cells (mDCs); CCR7+ myeloid dendritic cells (mDCs); CD40/CD86+ monocytes; CD38+ CD56-dim natural killer (NK) cells"	"4"	"myeloid dendritic cell & CD86-positive; myeloid dendritic cell & CCR7+; monocyte & CD40, CD86; natural killer cell & CD38+, CD56-dim"	"4"	"CL_0000782"	"PR_000001412"	"cell type frequency"	"positive"	"none"	"1"	"Day"	"time of vaccination (first dose)"	"ebola virus"	""	"rVSV-EBOV"	"VO_0004660"	""	"1d vs 0d"	"adults (18-55)"	""	""	"28854372"	"2017"	"Fig 2A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/figure/fig2/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/"	"adults"	"18"	"55"	"years"	"3"	"24"	"28854372_3_24"
""	"peripheral blood mononuclear cell"	"CD40/CD86+ plasma dendritic cells (pDCs); CD86+ myeloid dendritic cells (mDCs); CD86+ CD16+ inflammatory monocytes; CD40/CD86+ monocytes; CD16+ inflammatory monocytes; CD38+ CD56dim natural killer (NK) cells; NKG2D+ CD56dim natural killer (NK) cells; CD56bright natural killer (NK) cells"	"8"	"plasmacytoid dendritic cell & CD40+, CD86+; myeloid dendritic cell & CD86-positive; monocyte & CD86-positive, CD16-positive, inflammatory; monocyte & CD40, CD86; monocyte & CD16-positive, inflammatory; natural killer cell & CD38+, CD56-dim; natural killer cell & CD56-dim, NKG2D+; natural killer cell & CD56-bright"	"8"	"CL_0000784"	"PR_P29965, PR_000001412 "	"cell type frequency"	"positive"	"none"	"3"	"Days"	"time of vaccination (first dose)"	"ebola virus"	""	"rVSV-EBOV"	"VO_0004660"	""	"3d vs 0d"	"adults (18-55)"	""	""	"28854372"	"2017"	"Fig 2A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/figure/fig2/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/"	"adults"	"18"	"55"	"years"	"4"	"25"	"28854372_4_25"
""	"peripheral blood mononuclear cell"	"interferon-gamma-positive T cells"	"1"	"T cell & IFNG+"	"1"	"CL_0000084"	"PR:000000017"	"cell type frequency"	"up"	"none"	"28"	"Days"	"time of vaccination (second dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Victoria/361/2011(H3N2)); influenza B virus (B/Wisconsin/01/2010)"	"2012"	"Imuvac"	"VO_0003144"	""	"28d (postboost) vs 0d (pre-imm)"	"children (14-26mo)"	""	""	"26755593"	"2016"	"Fig 2B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/figure/fig02/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/"	"children"	"14"	"26"	"months"	"1"	"26"	"26755593_1_26"
""	"peripheral blood mononuclear cell"	"interferon-gamma-positive T cells"	"1"	"T cell & IFNG+"	"1"	"CL_0000084"	"PR:000000017"	"cell type frequency"	"up"	"none"	"28"	"Days"	"time of vaccination (second dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Victoria/361/2011(H3N2)); influenza B virus (B/Wisconsin/01/2010)"	"2012"	"Fluad"	"VO_0004281"	""	"28d (postboost) vs 0d (pre-imm)"	"children (14-26mo)"	""	""	"26755593"	"2016"	"Fig 2B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/figure/fig02/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/"	"children"	"14"	"26"	"months"	"2"	"27"	"26755593_2_27"
""	"peripheral blood mononuclear cell"	"intereferon-gamma-positive, tumor-necrosis-factor-alfa-positive, interleukin-2-positive, effector memory CD4-positive, alpha-beta T cell; intereferon-gamma-negative, tumor-necrosis-factor-alfa-positive, interleukin-2-positive, effector memory CD4-positive, alpha-beta T cell"	"2"	"effector memory CD4-positive, alpha-beta T cell & TNF-a, IL-2+; effector memory CD4-positive, alpha-beta T cell & IFNG-, TNF-a+, IL-2+"	"2"	"CL_0000905"	"PR:000000134, PR:000001379"	"cell type frequency"	"up"	"none"	"28"	"Days"	"time of vaccination (second dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Victoria/361/2011(H3N2)); influenza B virus (B/Wisconsin/01/2010)"	"2012"	"Fluad"	"VO_0004281"	""	"28d (postboost) vs 0d (pre-imm)"	"children (14-27mo)"	""	""	"26755593"	"2016"	"Fig 2A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/figure/fig02/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/"	"children"	"14"	"27"	"months"	"3"	"28"	"26755593_3_28"
""	"peripheral blood mononuclear cell"	"B cell; CD4+ alpha-beta T cell; CD16+ CD56dim natural killer cell; CD8+ alpha-beta T cell; granulocyte; lymphocyte"	"6"	"B cell; CD4-positive, alpha-beta T cell; CD16-positive, CD56-dim natural killer cell, human; CD8-positive, alpha-beta T cell; granulocyte; lymphocyte"	"6"	"CL_0000236"	""	"cell type frequency"	"down"	"none"	"1"	"Days"	"time of vaccination (first dose)"	"human immunodeficiency virus 1"	""	"MRKAd5/HIV"	"VO_0003133"	""	"1d vs 0d"	"adults (20-50)"	""	""	"23151505"	"2012"	"Fig. 1E"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/figure/fig01/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/"	"adults"	"20"	"50"	"years"	"1"	"29"	"23151505_1_29"
""	"peripheral blood mononuclear cell"	"CD14+ CD16- classical monocyte"	"1"	"CD14-positive, CD16-negative classical monocyte"	"1"	"CL_0002057"	""	"cell type frequency"	"up"	"none"	"1"	"Days"	"time of vaccination (first dose)"	"human immunodeficiency virus 1"	""	"MRKAd5/HIV"	"VO_0003133"	""	"1d vs 0d"	"adults (20-50)"	""	""	"23151505"	"2012"	"Fig. 1E"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/figure/fig01/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/"	"adults"	"20"	"50"	"years"	"2"	"30"	"23151505_2_30"
""	"peripheral blood mononuclear cell"	"CD14+ CD16- classical monocyte; CD16+ CD56-dim natural killer cell"	"2"	"CD14-positive, CD16-negative classical monocyte; CD16-positive, CD56-dim natural killer cell, human"	"2"	"CL_0002057"	""	"cell type frequency"	"up"	"none"	"3"	"Days"	"time of vaccination (first dose)"	"human immunodeficiency virus 1"	""	"MRKAd5/HIV"	"VO_0003133"	""	"3d vs 0d"	"adults (20-50)"	""	""	"23151505"	"2012"	"Fig. 1E"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/figure/fig01/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/"	"adults"	"20"	"50"	"years"	"3"	"31"	"23151505_3_31"
""	"peripheral blood mononuclear cell"	"B cell"	"1"	"B cell"	"1"	"CL_0000236"	""	"cell type frequency"	"down"	"none"	"3"	"Days"	"time of vaccination (first dose)"	"human immunodeficiency virus 1"	""	"MRKAd5/HIV"	"VO_0003133"	""	"3d vs 0d"	"adults (20-50)"	""	""	"23151505"	"2012"	"Fig. 1E"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/figure/fig01/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/"	"adults"	"20"	"50"	"years"	"4"	"32"	"23151505_4_32"
""	"peripheral blood mononuclear cell"	"CD4-positive, CD25-positive, alpha-beta regulatory T cell"	"1"	"CD4-positive, CD25-positive, alpha-beta regulatory T cell"	"1"	"CL_0000792"	""	"cell type frequency"	"up"	"low responders"	"7"	"Days"	"time of vaccination (first dose)"	"mycobacterium bovis BCG"	""	"Modified Vaccinia Ankara (MVA) virus vaccine vector"	"VO_0003120"	""	"7d vs 0d"	"adult (18-55)"	""	""	"23844129"	"2013"	"Fig 2b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700883/figure/pone-0067922-g002/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23844129"	"adults"	"18"	"55"	"years"	"1"	"33"	"23844129_1_33"
""	"peripheral blood mononuclear cell"	"plasma cell"	"1"	"plasma cell"	"1"	"CL_0000786"	""	"cell type frequency"	"positive"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"neisseria meningitidis"	""	"Menveo; ACWYVax"	"VO_0001246; VO_0003138"	""	"correlated with MenC SBA at day 28"	"adults (30-70)"	""	""	"28137280"	"2017"	"Table 2"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282650/table/Tab2/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=28137280"	"adults, seniors"	"30"	"70"	"years"	"1"	"34"	"28137280_1_34"
""	"peripheral blood mononuclear cell"	"IFN-gamma+ antigen specific T cell"	"1"	"T cell & IFNG+"	"1"	"CL_0000084"	"PR:000000017"	"cell type frequency"	"up"	"none"	"8"	"Days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"8d vs 0d"	"seniors (50-75)"	""	""	"27764254"	"2016"	"Fig 1a, text"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g001/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/"	"adults, seniors"	"50"	"75"	"years"	"1"	"35"	"27764254_1_35"
""	"peripheral blood mononuclear cell"	"IFN-gamma+ antigen specific T cell"	"1"	"T cell & IFNG+"	"1"	"CL_0000084"	"PR:000000017"	"cell type frequency"	"up"	"none"	"14"	"Days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"14d vs 0d"	"seniors (50-75)"	""	""	"27764254"	"2016"	"Fig 1a, text"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g001/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/"	"adults, seniors"	"50"	"75"	"years"	"2"	"36"	"27764254_2_36"
""	"peripheral blood mononuclear cell"	"IFN-gamma+ antigen specific T cell"	"1"	"T cell & IFNG+"	"1"	"CL_0000084"	"PR:000000017"	"cell type frequency"	"up"	"none"	"28"	"Days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"28d vs 0d"	"seniors (50-75)"	""	""	"27764254"	"2016"	"Fig 1a, text"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g001/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/"	"adults, seniors"	"50"	"75"	"years"	"3"	"37"	"27764254_3_37"
""	"peripheral blood mononuclear cell"	"IFN-gamma+ antigen specific T cell"	"1"	"T cell & IFNG+"	"1"	"CL_0000084"	"PR:000000017"	"cell type frequency"	"down"	"none"	"28"	"Days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"28d vs 8d"	"seniors (50-75)"	""	""	"27764254"	"2016"	"Fig 1a, text"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g001/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/"	"adults, seniors"	"50"	"75"	"years"	"4"	"38"	"27764254_4_38"
""	"peripheral blood mononuclear cell"	"CD38+HLADR+ VZV tetramer+ cells (% of VZV tetramer CD4 T cells)"	"1"	"CD4-positive, alpha-beta T cell & CD38+, HLA-DR+, VZV tetramer+"	"1"	"CL_0000624"	"PR:000001408"	"cell type frequency"	"up"	"none"	"8"	"Days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"8d vs 0d"	"seniors (50-75)"	""	""	"27764254"	"2016"	"Fig 6b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g006/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/"	"adults, seniors"	"50"	"75"	"years"	"5"	"39"	"27764254_5_39"
""	"peripheral blood mononuclear cell"	"CD38+ HLADR+ VZV tetramer+ cells (% of VZV tetramer CD4 T cells)"	"1"	"CD4-positive, alpha-beta T cell & CD38+, HLA-DR+, VZV tetramer+"	"1"	"CL_0000624"	"PR:000001408"	"cell type frequency"	"up"	"none"	"14"	"Days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"14d vs 0d"	"seniors (50-75)"	""	""	"27764254"	"2016"	"Fig 6b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g006/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/"	"adults, seniors"	"50"	"75"	"years"	"6"	"40"	"27764254_6_40"
""	"peripheral blood mononuclear cell"	"interferon-gamma+ CD4 T cells"	"1"	"CD4-positive, alpha-beta T cell & IFNG+"	"1"	"CL_0000624"	"PR:000000017"	"cell type frequency"	"up"	"none"	"29"	"Days"	"time of vaccination (first dose)"	"mycobacterium bovis BCG"	""	"VPM1002"	"VO_0003131"	""	"29d vs 0d"	"adults (18-55)"	""	""	"23290835"	"2013"	"Fig 3A"	"https://www.sciencedirect.com/science/article/pii/S0264410X12018403?via%3Dihub#fig0015"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23290835"	"adults"	"18"	"55"	"years"	"1"	"41"	"23290835_1_41"
""	"peripheral blood mononuclear cell"	"triple-positive (interferon-gamma, tumor necrosis factor-alpha, interleukin-2) CD4 T cells"	"1"	"CD4-positive, alpha-beta T cell & IFNG+, TNF-a+, IL-2+"	"1"	"CL_0000624"	"PR:000000017, PR:000000134, PR:000001379"	"cell type frequency"	"up"	"none"	"29"	"Days"	"time of vaccination (first dose)"	"mycobacterium bovis BCG"	""	"BCG vaccine; VPM1002"	"VO_0000771; VO_0003131"	""	"VPM1002-3 vs BCG vaccine"	"adults (18-55)"	""	""	"23290835"	"2013"	"Fig 3B"	"https://www.sciencedirect.com/science/article/pii/S0264410X12018403?via%3Dihub#fig0015"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23290835"	"adults"	"18"	"55"	"years"	"2"	"42"	"23290835_2_42"
""	"blood"	"CD8+ interleukin-17+ (IL-17+) cells"	"1"	"CD8-positive, alpha-beta T cell & IL17A+"	"1"	"CL_0000625"	"PR:000001138"	"cell type frequency"	"up"	"none"	"14"	"Days"	"time of vaccination (first dose)"	"mycobacterium bovis BCG"	""	"BCG vaccine; VPM1002"	"VO_0000771; VO_0003131"	""	"14d vs 0d"	"infants"	""	""	"27974398"	"2017"	"Fig 4B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299117/figure/F4/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27974398"	"infants"	""	""	""	"1"	"43"	"27974398_1_43"
""	"blood"	"CD8+ interleukin-17+ (IL-17+) cells"	"1"	"CD8-positive, alpha-beta T cell & IL17A+"	"1"	"CL_0000625"	"PR:000001138"	"cell type frequency"	"up"	"none"	"6"	"Months"	"time of vaccination (first dose)"	"mycobacterium bovis BCG"	""	"BCG vaccine; VPM1002"	"VO_0000771; VO_0003131"	""	"6m vs 0m"	"infants"	""	""	"27974398"	"2017"	"Fig 4B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299117/figure/F4/"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27974398"	"infants"	""	""	""	"2"	"44"	"27974398_2_44"
""	"peripheral blood mononuclear cell"	"white blood cell; neutrophil; lymphocyte; eosinophil"	"4"	"leukocyte; neutrophil; lymphocyte; eosinophil"	"4"	"CL_0000738"	""	"cell type frequency"	"down"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-VAX"	"VO_0000121"	""	"7d vs 0d"	"adults (18-40)"	""	""	"17651872"	"2007"	"Text: Study Summaries and Clinical Observations"	""	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=17651872"	"adults"	"18"	"40"	"years"	"1"	"45"	"17651872_1_45"
""	"blood"	"switched IgG+ memory B cells (CD3-, CD19+, HLADR+, CD27+, IgG+); IgG+ memory B cells (CD3-, CD19+, HLADR+, CD27+, CD10-, CD20+, IgG+)"	"2"	"IgG memory B cell & CD3-, CD19+, CD27+, HLADR+, IgG+; IgG memory B cell & CD3-, CD19+, CD27+, CD10-, CD20+, HLADR+, IgG+"	"2"	"CL_0000979"	"PR:000001020, PR_000001002, PR:000001963"	"cell type frequency"	"positive"	"none"	"0"	"Days"	"time of vaccination (first dose)"	"hepatitis B virus"	""	"Twinrix"	"VO_0000113"	""	"predictive of anti-HBsAg ab titre"	"seniors (65-83)"	""	""	"26742691"	"2016"	"Fig 5b; Table 1"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729923/table/t1/"	"EM131 elderly cohort (65-83)"	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=26742691"	"seniors"	"65"	"83"	"years"	"1"	"46"	"26742691_1_46"
""	"blood"	"TEM2+ CD4+ T Cell; CD40+ pDC"	"2"	"CD4-positive, alpha-beta T cell & TEM2+; plasmacytoid dendritic cell & CD40+"	"2"	"CL_0000624"	"PR_Q96D21 "	"cell type frequency"	"negative"	"none"	"0"	"Days"	"time of vaccination (first dose)"	"hepatitis B virus"	""	"Twinrix"	"VO_0000113"	""	"correlated with anti-HBsAg ab titre"	"seniors (65-83)"	""	""	"26742691"	"2016"	"Fig 5a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729923/figure/f5"	"EM131 elderly cohort (65-83)"	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=26742691"	"seniors"	"65"	"83"	"years"	"2"	"47"	"26742691_2_47"
""	"peripheral blood mononuclear cell"	"memory B cell"	"1"	"memory B cell"	"1"	"CL_0000787"	""	"cell type frequency"	"up"	"none"	"28"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Fluarix"	"VO_0000045"	""	"28d vs 0d"	"adults(50-74)"	""	""	"27317456"	"2016"	"Text: Subjects Demographics and Memory B cell ELISPOT response"	""	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27317456"	"adults, seniors"	"50"	"74"	"years"	"1"	"48"	"27317456_1_48"
""	"peripheral blood mononuclear cell"	"IgG+ Antibody secreting cells"	"1"	"IgG plasmablast"	"1"	"CL_0000982"	""	"cell type frequency"	"up"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009"	"Fluvirin; Pandemrix"	"VO_0000046; VO_0000410"	""	"7d vs 0d"	"adults"	""	""	"24725414"	"2014"	"Fig 3a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F3/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"adults"	""	""	""	"1"	"49"	"24725414_1_49"
""	"peripheral blood mononuclear cell"	"CD40+ monocytes; CD38+ of CD8+ T cells; CD86+ monocytes; CD86+ of naive B cells; CD69+ of CD8+ T cells; CD25+ of CD8+ Tcells; CD38+ of IgD+CD27+ memory B cells; IL2+ of CD4+ T cells; HLA-DR+ of CD4+ T cells; CD103+ of CD4+ T cells; CD14+ of viable CD45+ cells (Total monocytes); CD80+ of IgD-CD27+ memory B cells; CD103+ of CD8+ T cells; IFNa+ of pDCs; HLA-DR+ of CD8+ T cells; IL4+ of CD4+ T cells"	"16"	"monocyte & CD40+; CD8-positive, alpha-beta T cell & CD38+; monocyte & CD86+; naive B cell & CD86+; CD8-positive, alpha-beta T cell & CD69+; CD8-positive, CD25-positive, alpha-beta regulatory T cell; memory B cell & CD27+, CD38+, IgD+; CD4-positive, alpha-beta T cell & IL-2+; CD4-positive, alpha-beta T cell & HLA-DR+; CD4-positive, alpha-beta T cell & CD103+; CD14-positive monocyte & CD45+, viable; IgD-negative memory B cell & CD80+, CD27+; CD8-positive, alpha-beta T cell & CD103+; dendritic cell & interferon alpha+; CD8-positive, alpha-beta T cell & HLA-DR+; CD4-positive, alpha-beta T cell & IL-4+"	"16"	"CL_0000576"	"PR:000001961"	"cell type frequency"	"up"	"none"	"1"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009"	"Fluvirin; Pandemrix"	"VO_0000046; VO_0000410"	""	"1d vs 0d"	"adults"	""	""	"24725414"	"2014"	"Fig 3d"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F3/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"adults"	""	""	""	"2"	"50"	"24725414_2_50"
""	"peripheral blood mononuclear cell"	"CD21+ plasmablast; IgA+ of IgD-CD27+ memory B cells"	"2"	"plasmablast & CD21+; IgA memory B cell & CD27+, IgD-"	"2"	"CL_0000980"	"PR:000001338"	"cell type frequency"	"down"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009"	"Fluvirin; Pandemrix"	"VO_0000046; VO_0000410"	""	"7d vs 0d"	"adults"	""	""	"24725414"	"2014"	"Fig 3d"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F3/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"adults"	""	""	""	"3"	"51"	"24725414_3_51"
""	"peripheral blood mononuclear cell"	"CD27hi CD38hi of CD20- B cells (plasmablasts); CD38+ of IgD-CD27+ memory B cells; CD86+ of CD20+ B cells; CD38+ of CD4+ T cells; CD86+ of Naive B Cells; IL4+ of CD4+ T cells; CD39+ of CD8+ T cells; CD86+ of IgD-CD27- memory B cells"	"8"	"plasmablast & CD27-hi, CD38-hi, CD20-; IgD-negative memory B cell & CD27+, CD38+; B cell & CD20+, CD86+; CD4-positive, alpha-beta T cell & CD38+; naive B cell & CD86+; CD4-positive, alpha-beta T cell & IL-4+; CD8-positive, alpha-beta T cell & CD39+; IgD-negative memory B cell & CD86+, CD27-"	"8"	"CL_0000980"	"PR:000001963, PR:000001408, PR:000001289"	"cell type frequency"	"up"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009"	"Fluvirin; Pandemrix"	"VO_0000046; VO_0000410"	""	"7d vs 0d"	"adults"	""	""	"24725414"	"2014"	"Fig 3d"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F3/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"adults"	""	""	""	"4"	"52"	"24725414_4_52"
""	"peripheral blood mononuclear cell"	"plasmablast"	"1"	"plasmablast"	"1"	"CL_0000980"	""	"cell type frequency"	"up"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009"	"Fluvirin; Pandemrix"	"VO_0000046; VO_0000410"	""	"low baseline titer group vs high baseline titer group"	"adults"	""	""	"24725414"	"2014"	"Fig 4c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F4/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"adults"	""	""	""	"5"	"53"	"24725414_5_53"
""	"peripheral blood mononuclear cell"	"IL22+ of CD161- CD4+ T cells; IL2+ of CD4+ T cells; CD38+ of transitional B cells; CD38+ of CD20+IgD-CD27+ B cells; CD38+ of IgD+CD27+ memory B cells; CD38+ of Naive B cells"	"6"	"CD4-positive, alpha-beta T cell & IL22+, CD161-; CD4-positive, alpha-beta T cell & IL-2+; transitional stage B cell & CD38+; B cell & CD20+, CD27+, CD38+, IgD-; memory B cell & CD27+, CD38+, IgD+; naive B cell & CD38+"	"6"	"CL_0000624"	"PR_000001383, PR_000025670 "	"cell type frequency"	"positive"	"none"	"0"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009"	"Fluvirin; Pandemrix"	"VO_0000046; VO_0000410"	""	"predictive of d28 HAI"	"adults"	""	""	"24725414"	"2014"	"Fig 6c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F6/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"adults"	""	""	""	"6"	"54"	"24725414_6_54"
""	"peripheral blood mononuclear cell"	"CD27+CCR7- of memory CD4+ T cells"	"1"	"CD4-positive, alpha-beta memory T cell & CD27+, CCR7-"	"1"	"CL_0000897"	"PR:000001963, PR_000001203 "	"cell type frequency"	"negative"	"none"	"0"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009"	"Fluvirin; Pandemrix"	"VO_0000046; VO_0000410"	""	"predictive of d28 HAI"	"adults"	""	""	"24725414"	"2014"	"Fig 6c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F6/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"adults"	""	""	""	"7"	"55"	"24725414_7_55"
""	"peripheral blood mononuclear cell"	"influenza-specific IgG secreting plasmablasts"	"1"	"IgG plasmablast & influenza-specific"	"1"	"CL_0000982"	""	"cell type frequency"	"positive"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Solomon Islands/3/2006(H1N1)); influenza A virus (A/Wisconsin/67/2005(H3N2)); influenza B virus (B/Malaysia/2506/2004); influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006); influenza B virus (B/Brisbane/60/2008)"	"2007, 2008, 2009"	"Fluarix; Fluvirin"	"VO_0000045; VO_0000046"	""	"correlated with HAI response at 28 days"	"young adults (18-50yrs)"	""	""	"21743478"	"2011"	"Fig 1e"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/"	"adults"	"18"	"50"	"years"	"1"	"56"	"21743478_1_56"
""	"peripheral blood mononuclear cell"	"influenza-specific IgM secreting plasmablasts"	"1"	"IgM plasmablast & influenza-specific"	"1"	"CL_0000983"	""	"cell type frequency"	"positive"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Solomon Islands/3/2006(H1N1)); influenza A virus (A/Wisconsin/67/2005(H3N2)); influenza B virus (B/Malaysia/2506/2004); influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006); influenza B virus (B/Brisbane/60/2008)"	"2007, 2008, 2009"	"Fluarix; Fluvirin"	"VO_0000045; VO_0000046"	""	"correlated with HAI response at 28 days"	"young adults (18-50yrs)"	""	""	"21743478"	"2011"	"Supp Fig 1b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/#SD1"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/"	"adults"	"18"	"50"	"years"	"2"	"57"	"21743478_2_57"
""	"peripheral blood mononuclear cell"	"influenza-specific IgA secreting plasmablasts"	"1"	"IgA plasmablast & influenza-specific"	"1"	"CL_0000984"	""	"cell type frequency"	"positive"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Solomon Islands/3/2006(H1N1)); influenza A virus (A/Wisconsin/67/2005(H3N2)); influenza B virus (B/Malaysia/2506/2004); influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006); influenza B virus (B/Brisbane/60/2008)"	"2007, 2008, 2009"	"Fluarix; Fluvirin"	"VO_0000045; VO_0000046"	""	"correlated with HAI response at 28 days"	"young adults (18-50yrs)"	""	""	"21743478"	"2011"	"Supp Fig 1b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/#SD1"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/"	"adults"	"18"	"50"	"years"	"3"	"58"	"21743478_3_58"
""	"peripheral blood mononuclear cell"	"influenza-specific IgG secreting plasmablasts"	"1"	"IgG plasmablast & influenza-specific"	"1"	"CL_0000982"	""	"cell type frequency"	"positive"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Solomon Islands/3/2006(H1N1)); influenza A virus (A/Wisconsin/67/2005(H3N2)); influenza B virus (B/Malaysia/2506/2004); influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006); influenza B virus (B/Brisbane/60/2008)"	"2007, 2008, 2009"	"Fluarix; Fluvirin"	"VO_0000045; VO_0000046"	""	"correlated with total plasmablast"	"young adults (18-50yrs)"	""	""	"21743478"	"2011"	"Fig 1d"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/"	"adults"	"18"	"50"	"years"	"4"	"59"	"21743478_4_59"
""	"peripheral blood mononuclear cell"	"influenza-specific IgG secreting plasmablasts"	"1"	"IgG plasmablast & influenza-specific"	"1"	"CL_0000982"	""	"cell type frequency"	"positive"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	"FluMist"	"VO_0000044"	""	"correlated with total plasmablast"	"young adults (18-50yrs)"	""	""	"21743478"	"2011"	"Fig 1d"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/"	"adults"	"18"	"50"	"years"	"5"	"60"	"21743478_5_60"
""	"blood"	"naive B cells (CD19-positive, IgD-negative, CD27-negative) (CL_0000788); memory B cells (CD19+, IgD-, CD27+) (CL_0001053); transitional B cells (CD19+, CD24+, CD38+) (CL_0000818)"	"3"	"naive B cell & CD19+, CD27-, IgD-; IgD-negative memory B cell & CD19+, CD27+; transitional stage B cell & CD19+, CD24+, CD38+"	"3"	"CL_0000788"	"PR_000001002, PR:000001963"	"cell type frequency"	"up"	"none"	"27 to 33"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Fluzone"	"VO_0000047"	""	"(27 to 33d) vs 0d"	"children (0.5-14yrs)"	""	""	"24495909"	"2014"	"Fig 1"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/"	"infants, children"	"0.5"	"14"	"years"	"1"	"61"	"24495909_1_61"
""	"blood"	"plasmablasts (CD19+, CD27+, CD38+)"	"1"	"plasmablast & CD19+, CD27+, CD38+"	"1"	"CL_0000980"	"PR_000001002, PR:000001963, PR:000001408"	"cell type frequency"	"up"	"none"	"6 to 8"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Fluzone"	"VO_0000047"	""	"(6 to 8)d vs 0d"	"children (0.5-14yrs)"	""	""	"24495909"	"2014"	"Fig 1"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/"	"infants, children"	"0.5"	"14"	"years"	"2"	"62"	"24495909_2_62"
""	"blood"	"plasmablast; plasma cell"	"2"	"plasmablast; plasma cell"	"2"	"CL_0000980"	""	"cell type frequency"	"positive"	"none"	"6 to 8"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Fluzone"	"VO_0000047"	""	"(27 to 33d) vs 0d"	"children (0.5-14yrs)"	""	""	"24495909"	"2014"	"Fig 2"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F2/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/"	"infants, children"	"0.5"	"14"	"years"	"3"	"63"	"24495909_3_63"
""	"blood"	"plasmablast"	"1"	"plasmablast"	"1"	"CL_0000980"	""	"cell type frequency"	"positive"	"none"	"6 to 8"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Fluzone"	"VO_0000047"	""	"correlated with VN titer to B strain at 27 to 33 days"	"children (0.5-14yrs)"	""	""	"24495909"	"2014"	"Fig 2"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F2/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/"	"infants, children"	"0.5"	"14"	"years"	"4"	"64"	"24495909_4_64"
""	"blood"	"plasma cell"	"1"	"plasma cell"	"1"	"CL_0000786"	""	"cell type frequency"	"positive"	"none"	"6 to 8"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Fluzone"	"VO_0000047"	""	"correlated with VN titer to H1N1, H3N2, B strains at 27 to 33 days"	"children (0.5-14yrs)"	""	""	"24495909"	"2014"	"Fig 2"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F2/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/"	"infants, children"	"0.5"	"14"	"years"	"5"	"65"	"24495909_5_65"
""	"blood"	"plasmablast"	"1"	"plasmablast"	"1"	"CL_0000980"	""	"cell type frequency"	"positive"	"none"	"6 to 8"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"FluMist"	"VO_0000044"	""	"correlated with H3N2 VN titer at 27 to 33 days"	"children (0.5-14yrs)"	""	""	"24495909"	"2014"	"Text: Antibody-Secreting Cells Correlate With Antibody Titers on TIV Recipients"	""	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/"	"infants, children"	"0.5"	"14"	"years"	"6"	"66"	"24495909_6_66"
""	"peripheral blood mononuclear cell"	"natural killer cell"	"1"	"natural killer cell"	"1"	"CL_0000623"	""	"cell type frequency"	"up"	"none"	"0"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"seniors vs adults"	"seniors (>65yrs), adults (<65 yrs)"	""	""	"26682988"	"2015"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults, seniors"	""	""	"years"	"1"	"67"	"26682988_1_67"
""	"peripheral blood mononuclear cell"	"CD56dim CD16++ natural killer cells"	"1"	"CD16-positive, CD56-dim natural killer cell, human & CD16++"	"1"	"CL_0000939"	"PR_000001483"	"cell type frequency"	"up"	"none"	"0"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"seniors vs adults"	"seniors (>65yrs), adults (<65 yrs)"	""	""	"26682988"	"2015"	"Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	"5A is comparisions within group against baseline"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults, seniors"	""	""	"years"	"2"	"68"	"26682988_2_68"
""	"peripheral blood mononuclear cell"	"CD56++ natural killer cells; CD56++ CD16+ Natural Killer cells"	"2"	"natural killer cell & CD56-bright; natural killer cell & CD56++, CD16+"	"2"	"CL_0000623"	"PR:000001024"	"cell type frequency"	"up"	"none"	"0"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"adults vs seniors"	"seniors (>65yrs), adults (<65 yrs)"	""	""	"26682988"	"2015"	"Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults, seniors"	""	""	"years"	"3"	"69"	"26682988_3_69"
""	"peripheral blood mononuclear cell"	"natural killer cell"	"1"	"natural killer cell"	"1"	"CL_0000623"	""	"cell type frequency"	"up"	"none"	"1"	"Day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"seniors vs adults"	"seniors (>65yrs), adults (<65 yrs)"	""	""	"26682988"	"2015"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults, seniors"	""	""	"years"	"4"	"70"	"26682988_4_70"
""	"peripheral blood mononuclear cell"	"natural killer cell"	"1"	"natural killer cell"	"1"	"CL_0000623"	""	"cell type frequency"	"up"	"none"	"3"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"seniors vs adults"	"seniors (>65yrs), adults (<65 yrs)"	""	""	"26682988"	"2015"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults, seniors"	""	""	"years"	"5"	"71"	"26682988_5_71"
""	"peripheral blood mononuclear cell"	"natural killer cell"	"1"	"natural killer cell"	"1"	"CL_0000623"	""	"cell type frequency"	"up"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"seniors vs adults"	"seniors (>65yrs), adults (<65 yrs)"	""	""	"26682988"	"2015"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults, seniors"	""	""	"years"	"6"	"72"	"26682988_6_72"
""	"peripheral blood mononuclear cell"	"natural killer cell"	"1"	"natural killer cell"	"1"	"CL_0000623"	""	"cell type frequency"	"up"	"none"	"14"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"seniors vs adults"	"seniors (>65yrs), adults (<65 yrs)"	""	""	"26682988"	"2015"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults, seniors"	""	""	"years"	"7"	"73"	"26682988_7_73"
""	"peripheral blood mononuclear cell"	"natural killer cell"	"1"	"natural killer cell"	"1"	"CL_0000623"	""	"cell type frequency"	"up"	"none"	"1"	"Day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"1d vs 0d"	"seniors (>65yrs)"	""	""	"26682988"	"2015"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"seniors"	"65"	""	"years"	"8"	"74"	"26682988_8_74"
""	"peripheral blood mononuclear cell"	"natural killer cell"	"1"	"natural killer cell"	"1"	"CL_0000623"	""	"cell type frequency"	"up"	"none"	"3"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"3d vs 0d"	"seniors (>65yrs)"	""	""	"26682988"	"2015"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"seniors"	"65"	""	"years"	"9"	"75"	"26682988_9_75"
""	"peripheral blood mononuclear cell"	"natural killer cell"	"1"	"natural killer cell"	"1"	"CL_0000623"	""	"cell type frequency"	"up"	"none"	"14"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"14d vs 0d"	"seniors (>65yrs)"	""	""	"26682988"	"2015"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"seniors"	"65"	""	"years"	"10"	"76"	"26682988_10_76"
""	"peripheral blood mononuclear cell"	"natural killer cell"	"1"	"natural killer cell"	"1"	"CL_0000623"	""	"cell type frequency"	"down"	"none"	"1"	"Day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"1d vs 0d"	"adults (<65yrs)"	""	""	"26682988"	"2015"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults"	""	"65"	"years"	"11"	"77"	"26682988_11_77"
""	"peripheral blood mononuclear cell"	"CD56++ NK cells; CD56++ CD16+ NK cells"	"2"	"natural killer cell & CD56++; natural killer cell & CD56++, CD16+"	"2"	"CL_0000623"	"PR:000001024"	"cell type frequency"	"up"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"7d vs 0d"	"adults (<65yrs)"	""	""	"26682988"	"2015"	"Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults"	""	"65"	"years"	"12"	"78"	"26682988_12_78"
""	"peripheral blood mononuclear cell"	"CD56dim CD16++ NK cells; Natural Killer cells"	"2"	"CD16-positive, CD56-dim natural killer cell, human & CD16++; natural killer cell"	"2"	"CL_0000939"	"PR_000001483"	"cell type frequency"	"up"	"none"	"1"	"Day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"1 vs 0d"	"seniors (>65yrs)"	""	""	"26682988"	"2015"	"Fig 5A&C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"seniors"	"65"	""	"years"	"13"	"79"	"26682988_13_79"
""	"peripheral blood mononuclear cell"	"CD56++ NK cells; CD56++ CD16+ NK cells"	"2"	"natural killer cell & CD56++; natural killer cell & CD56++, CD16+"	"2"	"CL_0000623"	"PR:000001024"	"cell type frequency"	"down"	"none"	"1"	"Day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"1d vs 0d"	"seniors (>65yrs)"	""	""	"26682988"	"2015"	"Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"seniors"	"65"	""	"years"	"14"	"80"	"26682988_14_80"
""	"peripheral blood mononuclear cell"	"monocytes"	"1"	"monocyte"	"1"	"CL_0000576"	""	"cell type frequency"	"up"	"none"	"1"	"Day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"1d vs 0d"	"adults (<65yrs)"	""	""	"26682988"	"2015"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults"	""	"65"	"years"	"15"	"81"	"26682988_15_81"
""	"peripheral blood mononuclear cell"	"monocytes"	"1"	"monocyte"	"1"	"CL_0000576"	""	"cell type frequency"	"up"	"none"	"1"	"Day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"1d vs 0d"	"seniors (>65yrs)"	""	""	"26682988"	"2015"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"seniors"	"65"	""	"years"	"16"	"82"	"26682988_16_82"
""	"peripheral blood mononuclear cell"	"monocytes"	"1"	"monocyte"	"1"	"CL_0000576"	""	"cell type frequency"	"down"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"7d vs 0d"	"adults (<65yrs)"	""	""	"26682988"	"2015"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults"	""	"65"	"years"	"17"	"83"	"26682988_17_83"
""	"peripheral blood mononuclear cell"	"monocytes"	"1"	"monocyte"	"1"	"CL_0000576"	""	"cell type frequency"	"down"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"7d vs 0d"	"seniors (>65yrs)"	""	""	"26682988"	"2015"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"seniors"	"65"	""	"years"	"18"	"84"	"26682988_18_84"
""	"peripheral blood mononuclear cell"	"monocytes"	"1"	"monocyte"	"1"	"CL_0000576"	""	"cell type frequency"	"up"	"none"	"0"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"seniors vs adults"	"seniors (>65yrs), adults (<65 yrs)"	""	""	"26682988"	"2015"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults, seniors"	""	""	""	"19"	"85"	"26682988_19_85"
""	"peripheral blood mononuclear cell"	"monocytes"	"1"	"monocyte"	"1"	"CL_0000576"	""	"cell type frequency"	"up"	"none"	"1"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"seniors vs adults"	"seniors (>65yrs), adults (<65 yrs)"	""	""	"26682988"	"2015"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults, seniors"	""	""	""	"20"	"86"	"26682988_20_86"
""	"peripheral blood mononuclear cell"	"monocytes"	"1"	"monocyte"	"1"	"CL_0000576"	""	"cell type frequency"	"up"	"none"	"3"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"seniors vs adults"	"seniors (>65yrs), adults (<65 yrs)"	""	""	"26682988"	"2015"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults, seniors"	""	""	""	"21"	"87"	"26682988_21_87"
""	"peripheral blood mononuclear cell"	"monocytes"	"1"	"monocyte"	"1"	"CL_0000576"	""	"cell type frequency"	"up"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"seniors vs adults"	"seniors (>65yrs), adults (<65 yrs)"	""	""	"26682988"	"2015"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults, seniors"	""	""	""	"22"	"88"	"26682988_22_88"
""	"peripheral blood mononuclear cell"	"monocytes"	"1"	"monocyte"	"1"	"CL_0000576"	""	"cell type frequency"	"up"	"none"	"14"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"seniors vs adults"	"seniors (>65yrs), adults (<65 yrs)"	""	""	"26682988"	"2015"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults, seniors"	""	""	""	"23"	"89"	"26682988_23_89"
""	"peripheral blood mononuclear cell"	"CD14+ CD16- monocytes"	"1"	"CD14-positive, CD16-negative classical monocyte"	"1"	"CL_0002057"	""	"cell type frequency"	"down"	"none"	"3"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"3d vs 0d"	"adults (<65yrs)"	""	""	"26682988"	"2015"	"Fig S6C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults"	""	"65"	"years"	"24"	"90"	"26682988_24_90"
""	"peripheral blood mononuclear cell"	"CD14+ CD16+ monocytes"	"1"	"CD14-positive, CD16-positive monocyte"	"1"	"CL_0002397"	""	"cell type frequency"	"up"	"none"	"1"	"Day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"1d vs 0d"	"adults (<65yrs)"	""	""	"26682988"	"2015"	"Fig S6C"	" https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults"	""	"65"	"years"	"25"	"91"	"26682988_25_91"
""	"peripheral blood mononuclear cell"	"CD56++ CD16+ natural killer (NK) cells"	"1"	"natural killer cell & CD56++, CD16+"	"1"	"CL_0000623"	"PR_000001024, PR_000001483"	"cell type frequency"	"up"	"none"	"1"	"Day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"1d vs 0d"	"adults (<65yrs)"	""	""	"26682988"	"2015"	"Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults"	""	"65"	"years"	"26"	"92"	"26682988_26_92"
""	"peripheral blood mononuclear cell"	"CD14dim CD16++ monocytes"	"1"	"CD14-low, CD16-positive monocyte & CD14-dim, CD16++"	"1"	"CL_0002396"	"PR:000001889, PR_000001483"	"cell type frequency"	"up"	"none"	"3"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"3d vs 0d"	"adults (<65yrs)"	""	""	"26682988"	"2015"	"Fig S6C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"adults"	""	"65"	"years"	"27"	"93"	"26682988_27_93"
""	"peripheral blood mononuclear cell"	"CD14+ CD16- monocytes"	"1"	"CD14-positive, CD16-negative classical monocyte"	"1"	"CL_0002057"	""	"cell type frequency"	"up"	"none"	"14"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"14d vs 0d"	"seniors (>65yrs)"	""	""	"26682988"	"2015"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"seniors"	"65"	""	"years"	"28"	"94"	"26682988_28_94"
""	"peripheral blood mononuclear cell"	"CD14+ CD16+ monocytes"	"1"	"CD14-positive, CD16-positive monocyte"	"1"	"CL_0002397"	""	"cell type frequency"	"down"	"none"	"14"	"Days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Inactivated influenza vaccine"	"VO_0001176"	""	"14d vs 0d"	"seniors (>65yrs)"	""	""	"26682988"	"2015"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"seniors"	"65"	""	"years"	"29"	"95"	"26682988_29_95"
""	"peripheral blood mononuclear cell"	"activated CD4+ T cells"	"1"	"activated CD4-positive, alpha-beta T cell"	"1"	"CL_0000896"	""	"cell type frequency"	"down"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"high vs low inositol phosphate metabolism"	"adults (25-40/60-79)"	""	""	"28502771"	"2017"	"Fig 7F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711477/figure/F7/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711477/"	"adults, seniors"	"25"	"79"	"years"	"1"	"96"	"28502771_1_96"
""	"peripheral blood mononuclear cell"	"neutrophil"	"1"	"neutrophil"	"1"	"CL_0000775"	""	"cell type frequency"	"down"	"none"	"3"	"Days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"high vs low inositol phosphate metabolism"	"adults (25-40/60-79)"	""	""	"28502771"	"2017"	"Fig 7F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711477/figure/F7/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711477/"	"adults, seniors"	"25"	"79"	"years"	"2"	"97"	"28502771_2_97"
""	"peripheral blood mononuclear cell"	"VZV antigen-reactive CD4 T cells"	"1"	"CD4-positive, alpha-beta T cell & VZV antigen-reactive"	"1"	"CL_0000624"	""	"cell type frequency"	"up"	"none"	"8"	"Days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"8d vs 0d"	"seniors (52-75)"	""	""	"27030598"	"2016"	"text right before Fig 3, Fig 3a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/figure/F3/"	"Influence of vaccination on the CD4 T cell receptor repertoire of VZV-reactive cells"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/"	"adults, seniors"	"52"	"75"	"years"	"1"	"98"	"27030598_1_98"
""	"peripheral blood mononuclear cell"	"VZV antigen-reactive CD4 T cells"	"1"	"CD4-positive, alpha-beta T cell & VZV antigen-reactive"	"1"	"CL_0000624"	""	"cell type frequency"	"up"	"none"	"14"	"Days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"14d vs 0d"	"seniors (52-75)"	""	""	"27030598"	"2016"	"text right before Fig 3, Fig 3a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/figure/F3/"	"Influence of vaccination on the CD4 T cell receptor repertoire of VZV-reactive cells"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/"	"adults, seniors"	"52"	"75"	"years"	"2"	"99"	"27030598_2_99"
""	"peripheral blood mononuclear cell"	"VZV antigen-reactive CD4 T cells"	"1"	"CD4-positive, alpha-beta T cell & VZV antigen-reactive"	"1"	"CL_0000624"	""	"cell type frequency"	"up"	"none"	"28"	"Days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"28d vs 0d"	"seniors (52-75)"	""	""	"27030598"	"2016"	"text right before Fig 3, Fig 3a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/figure/F3/"	"Influence of vaccination on the CD4 T cell receptor repertoire of VZV-reactive cells"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/"	"adults, seniors"	"52"	"75"	"years"	"3"	"100"	"27030598_3_100"
""	"blood"	"white blood cell"	"1"	"leukocyte"	"1"	"CL_0000738"	""	"cell type frequency"	"up"	"males in group 2 (4mo: HBV & OPV. 9mo: MV+DTP (i.m). 11mo: outstanding vaccines)"	"28"	"Days"	"time of vaccination (first dose)"	"measles virus strain Edmonston-Zagreb; corynebacterium diphtheriae; clostridium tetani; human poliovirus 1; human poliovirus 2; human poliovirus 3"	""	"Measles virus vaccine; Diphtheria-Tetanus-Pertussis vaccine"	"VO_0000654; VO_0000738"	""	"group 2 (4mo: HBV & OPV. 9mo: MV+DTP (i.m). 11mo: outstanding vaccines) vs groups 1 (4mo: 3rd dose of DTP, HBV, OPV. 9mo: 1 i.m dose of MV Edmonstron Zagreb strain. 11mo: outstanding vaccines) & 3 (4mo: HBV & OPV. 9mo: DTP. 11mo: outstanding vaccines) "	"infants (4mo)"	""	""	"27436422"	"2016"	"Table 1"	"https://academic.oup.com/view-large/78928196"	""	""	"https://academic.oup.com/cid/article/63/9/1213/2576500"	"infants"	"4"	"4"	"months"	"1"	"101"	"27436422_1_101"
""	"blood"	"lymphocyte"	"1"	"lymphocyte"	"1"	"CL_0000542"	""	"cell type frequency"	"down"	"males in group 2 (4mo: HBV & OPV. 9mo: MV+DTP (i.m). 11mo: outstanding vaccines)"	"28"	"Days"	"time of vaccination (first dose)"	"measles virus strain Edmonston-Zagreb; corynebacterium diphtheriae; clostridium tetani; human poliovirus 1; human poliovirus 2; human poliovirus 3"	""	"Measles virus vaccine; Diphtheria-Tetanus-Pertussis vaccine"	"VO_0000654; VO_0000738"	""	"group 2 (4mo: HBV & OPV. 9mo: MV+DTP (i.m). 11mo: outstanding vaccines) vs groups 1 (4mo: 3rd dose of DTP, HBV, OPV. 9mo: 1 i.m dose of MV Edmonstron Zagreb strain. 11mo: outstanding vaccines) & 3 (4mo: HBV & OPV. 9mo: DTP. 11mo: outstanding vaccines) "	"infants (4mo)"	""	""	"27436422"	"2016"	"Table 1"	"https://academic.oup.com/view-large/78928196"	""	""	"https://academic.oup.com/cid/article/63/9/1213/2576500"	"infants"	"4"	"4"	"months"	"2"	"102"	"27436422_2_102"
""	"peripheral blood mononuclear cell"	"plasmacytoid dendritic cell; NK Cells (CD14-/CD19-/CD3-/NK/CD107A+/K562); NK Cells (CD14-/CD19-/CD3-/NK/IFNg+/K562); NK Cells (CD14-/CD19-/CD3-/NK/TNFa+/K562)"	"4"	"plasmacytoid dendritic cell; natural killer cell & CD14-, CD19-, CD3-, CD107a+, K562 cells; natural killer cell & CD14-, CD19-, CD3-, IFNG+, K562 cells; natural killer cell & CD14-, CD19-, CD3-, TNF-a+, K562 cells"	"4"	"CL_0000784"	""	"cell type frequency"	"up"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"7d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 4g-i"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"1"	"103"	"28687661_1_103"
""	"peripheral blood mononuclear cell"	"NK cells (CD14-/CD20-/CD3-/NK); NK cells (CD14-/CD20-/CD3-/NK/NKG2A+); NK cells (CD14-/CD20-/CD3-/NK/NKP46+)"	"3"	"natural killer cell & CD14-, CD20-, CD3-; NKGA2-positive natural killer cell & CD14-, CD20-, CD3-; natural killer cell & CD14-, CD20-, CD3-, NKG2-A/B-activating NK receptor+"	"3"	"CL_0000623"	"PR:000001889, PR:000001289, PR:000001020"	"cell type frequency"	"down"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"7d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 4d-f"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"2"	"104"	"28687661_2_104"
""	"peripheral blood mononuclear cell"	"B cells CD3-/CD19+CD20+/IgD-IgM-/CD27+; T cells CD3+/CD4+/CD28+; T cells CD3+/CD4+/Ki67+; T cells CD3+/CD8+/CD28+; T cells CD3+/CD8+/Ki67+"	"5"	"B cell & CD3-, CD19+, CD20+, CD27+, IgD-, IgM-; CD4-positive, alpha-beta T cell & CD3+, CD28+; CD4-positive, alpha-beta T cell & CD3+, pKI-67+; CD8-positive, alpha-beta T cell & CD3+, CD28+; CD8-positive, alpha-beta T cell & CD3+, pKI-67+"	"5"	"CL_0000236"	"PR:000001020, PR_000001002, PR:000001289, PR:000001963"	"cell type frequency"	"down"	"none"	"7"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"7d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 5d-h"	" https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"3"	"105"	"28687661_3_105"
""	"peripheral blood mononuclear cell"	"Monocytes (CD14+); NK cells (CD14-/CD20-/CD3-/NK/NKP46+)"	"2"	"CD14-positive monocyte; natural killer cell & CD14-, CD20-, CD3-, NKG2-A/B-activating NK receptor+"	"2"	"CL_0001054"	""	"cell type frequency"	"down"	"none"	"14"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"14d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 4a, Fig 4f, "	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"4"	"106"	"28687661_4_106"
""	"peripheral blood mononuclear cell"	"T cells CD3+/CD4+/Ki67+; T cells CD3+/CD8+/Ki67+"	"2"	"CD4-positive, alpha-beta T cell & CD3+, pKI-67+; CD8-positive, alpha-beta T cell & CD3+, pKI-67+"	"2"	"CL_0000624"	"PR:000001020, PR:000029630"	"cell type frequency"	"down"	"none"	"14"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"14d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 5f, Fig 5h"	" https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"5"	"107"	"28687661_5_107"
""	"peripheral blood mononuclear cell"	"plasmacytoid dendritic cell; B cells CD3-/CD19+CD20+; B cells CD3-/CD19+CD20+/IgD-IgM+/CD27+; T cells Cd14-/CD3+/CD4+/IL2+/ENV"	"4"	"plasmacytoid dendritic cell; B cell & CD3-, CD19+, CD20+; IgM memory B cell & CD3-, CD19+, CD20+, CD27+; CD4-positive, alpha-beta T cell & CD14-, CD3+, IL2+, ENV"	"4"	"CL_0000784"	""	"cell type frequency"	"up"	"none"	"28"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"28d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	"text (Vaccination with YF-17D induces...), Fig 4C, Fig 5A-B, Fig 5J"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"6"	"108"	"28687661_6_108"
""	"peripheral blood mononuclear cell"	"NK cells (CD14-/CD20-/CD3-/NK); NK cells (CD14-/CD20-/CD3-/NK/NKG2A+); NK cells (CD14-/CD20-/CD3-/NK/NKP46+)"	"3"	"natural killer cell & CD14-, CD20-, CD3-; NKGA2-positive natural killer cell & CD14-, CD20-, CD3-; natural killer cell & CD14-, CD20-, CD3-, NKG2-A/B-activating NK receptor+"	"3"	"CL_0000623"	"PR:000001889, PR:000001289, PR:000001020"	"cell type frequency"	"down"	"none"	"28"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"28d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 4D-F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/ "	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"7"	"109"	"28687661_7_109"
""	"peripheral blood mononuclear cell"	"T cells CD3+/CD4+/CD28+; T cells CD3+/CD4+/Ki67+; T cells CD3+/CD8+/Ki67+"	"3"	"CD4-positive, alpha-beta T cell & CD3+, CD28+; CD4-positive, alpha-beta T cell & CD3+, pKI-67+; CD8-positive, alpha-beta T cell & CD3+, pKI-67+"	"3"	"CL_0000624"	"PR:000001020, PR:000001841"	"cell type frequency"	"down"	"none"	"28"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"28d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	" Fig 5E-F, Fig 5H"	" https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"8"	"110"	"28687661_8_110"
""	"peripheral blood mononuclear cell"	"DC (NK-/CD123)"	"1"	"dendritic cell & CD123+, NK-"	"1"	"CL_0000451"	"PR:000001865"	"cell type frequency"	"up"	"none"	"86"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"86d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 4C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/ "	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"9"	"111"	"28687661_9_111"
""	"peripheral blood mononuclear cell"	"B cells CD3-/CD19+CD20+; B cells CD3-/CD19+CD20+/IgD-IgM+/CD27+; B cells CD3-/CD19+CD20+/IgD-IgM-/CD27+; T cells CD14-/CD3+/CD4+/IL2+/NS1"	"4"	"B cell & CD3-, CD19+, CD20+; IgM memory B cell & CD3-, CD19+, CD20+, CD27+; B cell & CD3-, CD19+, CD20+, CD27+, IgD-, IgM-; CD4-positive, alpha-beta T cell & CD14-, CD3+, IL2+, NS1"	"4"	"CL_0000236"	"PR:000001020, PR_000001002, PR:000001289"	"cell type frequency"	"up"	"none"	"86"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"86d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 5A, 5C, 5D, 5I"	" https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"10"	"112"	"28687661_10_112"
""	"peripheral blood mononuclear cell"	"NK cells (CD14-/CD20-/CD3-/NK); NK cells (CD14-/CD20-/CD3-/NK/NKG2A+); NK cells (CD14-/CD20-/CD3-/NK/NKP46+)"	"3"	"natural killer cell & CD14-, CD20-, CD3-; NKGA2-positive natural killer cell & CD14-, CD20-, CD3-; natural killer cell & CD14-, CD20-, CD3-, NKG2-A/B-activating NK receptor+"	"3"	"CL_0000623"	"PR:000001889, PR:000001289, PR:000001020"	"cell type frequency"	"down"	"none"	"86"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"86d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 4D, 4E, 4F,"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/ "	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"11"	"113"	"28687661_11_113"
""	"peripheral blood mononuclear cell"	"T cells CD3+/CD4+/Ki67+; T cells CD3+/CD8+/Ki67+"	"2"	"CD4-positive, alpha-beta T cell & CD3+, pKI-67+; CD8-positive, alpha-beta T cell & CD3+, pKI-67+"	"2"	"CL_0000624"	"PR:000001020, PR:000029630"	"cell type frequency"	"down"	"none"	"86"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"86d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 5F, 5H"	" https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"12"	"114"	"28687661_12_114"
""	"peripheral blood mononuclear cell"	"CD11c-positive DC; plasmacytoid dendritic cell"	"2"	"dendritic cell & CD11c+; plasmacytoid dendritic cell"	"2"	"CL_0000451"	"PR:000001013"	"cell type frequency"	"up"	"none"	"86"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"86d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	"text, Fig 4B-C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"13"	"115"	"28687661_13_115"
""	"peripheral blood mononuclear cell"	"B cells CD3-/CD19+CD20+"	"1"	"B cell & CD3-, CD19+, CD20+"	"1"	"CL_0000236"	"PR:000001020, PR_000001002, PR:000001289"	"cell type frequency"	"up"	"none"	"14"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"14d vs 0d"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"14"	"116"	"28687661_14_116"
""	"peripheral blood mononuclear cell"	"DC HLA-DR+CD11c+"	"1"	"dendritic cell & CD11c+, HLA-DR+"	"1"	"CL_0000451"	"PR:000001013"	"cell type frequency"	"down"	"none"	"14"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"flavivirus infected vs naive participants"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 6a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F6/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"15"	"117"	"28687661_15_117"
""	"peripheral blood mononuclear cell"	"DC HLA-DR+CD11c+"	"1"	"dendritic cell & CD11c+, HLA-DR+"	"1"	"CL_0000451"	"PR:000001013"	"cell type frequency"	"down"	"none"	"28"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"flavivirus infected vs naive participants"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 6a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F6/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"16"	"118"	"28687661_16_118"
""	"peripheral blood mononuclear cell"	"NK cells NK/CD107a+/K562"	"1"	"natural killer cell & CD107a+, K562 cells"	"1"	"CL_0000623"	"PR:000002060"	"cell type frequency"	"up"	"none"	"28"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"flavivirus infected vs naive participants"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 6b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F6/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"17"	"119"	"28687661_17_119"
""	"peripheral blood mononuclear cell"	"NK cells NK/TNFa+/K562"	"1"	"natural killer cell & TNF-a+, K562 cells"	"1"	"CL_0000623"	"PR:000000134"	"cell type frequency"	"up"	"none"	"86"	"Days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D"	"VO_0003134"	""	"flavivirus infected vs naive participants"	"adults (25-42)"	""	""	"28687661"	"2017"	"Fig 6b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F6/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"adults"	"25"	"42"	"years"	"18"	"120"	"28687661_18_120"
""	"serum"	"TIV-specific CD8+ GRZ+ T lymphocyte cells"	"1"	"CD8-positive, alpha-beta T cell & GZMB+, TIV-specific"	"1"	"CL_0000625"	"PR:000003499"	"cell type frequency"	"up"	"none"	"21"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Victoria/361/2011(H3N2)); influenza B virus (B/Wisconsin/01/2010)"	"2012"	"2012-2013 seasonal trivalent inactivated influenza vaccine (TIV)"	"VO_0004899"	""	"S2 vs S1 as defined by hierarchical clustering of gene expression"	"adults (18-45)"	""	""	"30843873"	"2019"	"Fig 4e"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/figure/F4/"	"Clusters S1 and S2 were defined based on hierarchical clustering of gene expression and were shown to be enriched with significantly different levels of influenza specific MN antibodies as well as vaccination routes for d21/d0."	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/"	"adults"	"18"	"45"	"years"	"1"	"121"	"30843873_1_121"
""	"serum"	"T cell responder TIV-specific CD8+ GRZ+"	"1"	"CD8-positive, alpha-beta T cell & GZMB+, TIV-specific"	"1"	"CL_0000625"	"PR:000003499"	"cell type frequency"	"up"	"none"	"21"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Victoria/361/2011(H3N2)); influenza B virus (B/Wisconsin/01/2010)"	"2012"	"2012-2013 seasonal trivalent inactivated influenza vaccine (TIV)"	"VO_0004899"	""	"S2 vs S1 as defined by hierarchical clustering of gene expression. Both clusters d21/d0, where each cluster was enriched for a different vaccination route and different levels of antibody response. "	"adults (18-45)"	""	""	"30843873"	"2019"	"Fig 3f"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/figure/F3/"	"Clusters S1 and S2 were defined based on hierarchical clustering of gene expression and were shown to be enriched with significantly different levels of influenza specific MN antibodies as well as vaccination routes for d21/d0."	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/"	"adults"	"18"	"45"	"years"	"2"	"122"	"30843873_2_122"
""	"peripheral blood mononuclear cell"	"CD86+ myeloid dendritic cell (DC)"	"1"	"myeloid dendritic cell & CD86-positive"	"1"	"CL_0000782"	"PR_000001412"	"cell type frequency"	"up"	"none"	"1"	"day"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D vaccine"	"VO_0003134"	""	"1d vs 0d"	"adults (18-45)"	""	""	"19029902"	"2009"	"Suppl Fig 1c"	""	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/"	"adults"	"18"	"45"	"years"	"1"	"123"	"19029902_1_123"
""	"peripheral blood mononuclear cell"	"CD86+ myeloid dendritic cell (DC)"	"1"	"myeloid dendritic cell & CD86-positive"	"1"	"CL_0000782"	"PR_000001412"	"cell type frequency"	"up"	"none"	"3"	"days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D vaccine"	"VO_0003134"	""	"3d vs 1d"	"adults (18-45)"	""	""	"19029902"	"2009"	"Suppl Fig 1c"	""	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/"	"adults"	"18"	"45"	"years"	"2"	"124"	"19029902_2_124"
""	"peripheral blood mononuclear cell"	"CD86+ myeloid dendritic cell (DC); CD86+ monocyte"	"2"	"myeloid dendritic cell & CD86-positive; monocyte & CD86+"	"2"	"CL_0000782"	"PR_000001412"	"cell type frequency"	"up"	"none"	"3"	"days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D vaccine"	"VO_0003134"	""	"3d vs 0d"	"adults (18-45)"	""	""	"19029902"	"2009"	"Suppl Fig 1c"	""	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/"	"adults"	"18"	"45"	"years"	"3"	"125"	"19029902_3_125"
""	"peripheral blood mononuclear cell"	"CD86+ myeloid dendritic cell (DC)"	"1"	"myeloid dendritic cell & CD86-positive"	"1"	"CL_0000782"	"PR_000001412"	"cell type frequency"	"up"	"none"	"21"	"days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D vaccine"	"VO_0003134"	""	"21d vs 7d"	"adults (18-45)"	""	""	"19029902"	"2009"	"Suppl Fig 1c"	""	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/"	"adults"	"18"	"45"	"years"	"4"	"126"	"19029902_4_126"
""	"peripheral blood mononuclear cell"	"CD86+ plasmacytoid dendritic cell (pDC); CD86+ CD16+ inflammatory monocyte"	"2"	"plasmacytoid dendritic cell & CD86+; monocyte & CD86-positive, CD16-positive, inflammatory"	"2"	"CL_0000784"	"PR_000001412 "	"cell type frequency"	"up"	"none"	"7"	"days"	"time of vaccination (first dose)"	"yellow fever virus 17D"	""	"YF-17D vaccine"	"VO_0003134"	""	"7d vs 1d"	"adults (18-45)"	""	""	"19029902"	"2009"	"Suppl Fig 1c"	""	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/"	"adults"	"18"	"45"	"years"	"5"	"127"	"19029902_5_127"
""	"peripheral blood mononuclear cell"	"CD4+ T cells"	"1"	"CD4-positive, alpha-beta T cell"	"1"	"CL_0000624"	""	"cell type frequency"	"up"	"none"	"0"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Fluarix"	"VO_0000045"	""	"females vs males"	"adults (50-74)"	""	""	"30873150"	"2019"	"Fig 4b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400991/figure/F4/"	"Caucasion older adults (50-74)"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400991/"	"adults, seniors"	"50"	"74"	"years"	"1"	"128"	"30873150_1_128"
""	"peripheral blood mononuclear cell"	"NK cell"	"1"	"natural killer cell"	"1"	"CL_0000623"	""	"cell type frequency"	"up"	"none"	"0"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	"Fluarix"	"VO_0000045"	""	"males vs females"	"adults (50-74)"	""	""	"30873150"	"2019"	"Fig 4b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400991/figure/F4/"	"Caucasion older adults (50-74)"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400991/"	"adults, seniors"	"50"	"74"	"years"	"2"	"129"	"30873150_2_129"
""	"blood"	"T cells IFNg producing VZV-specific CD4+"	"1"	"CD4-positive, alpha-beta T cell & IFNG+, VZV-specific"	"1"	"CL_0000624"	"PR:000000017"	"cell type frequency"	"up"	"none"	"72"	"hours"	"time of VZV antigen challenge"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"pre-vaccination vs 72hrs post-vaccination"	"adults (70-93)"	""	""	"30247603"	"2018"	"Fig 2e"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F2/"	"-2:1 ratio of female:male"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"seniors"	"70"	"93"	"years"	"1"	"130"	"30247603_1_130"
""	"body skin"	"T cells CD4+; T cells CD8+"	"2"	"CD4-positive, alpha-beta T cell; CD8-positive, alpha-beta T cell"	"2"	"CL_0000624"	""	"cell type frequency"	"up"	"none"	"3"	"days"	"time of VZV antigen challenge"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"pre-vaccination vs 3d post-VZV antigen challenge"	"adults (70-93)"	""	""	"30247603"	"2018"	"Fig 3a-c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F3/ "	"-2:1 ratio of female:male"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"seniors"	"70"	"93"	"years"	"2"	"131"	"30247603_2_131"
""	"body skin"	"T cells CD8+ Ki67+"	"1"	"CD8-positive, alpha-beta T cell & pKI-67+"	"1"	"CL_0000625"	"PR:000029630"	"cell type frequency"	"up"	"none"	"3"	"days"	"time of VZV antigen challenge"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"pre-vaccination vs 3d post-VZV antigen challenge"	"adults (70-93)"	""	""	"30247603"	"2018"	"Fig 4b-c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F4/"	"-2:1 ratio of female:male"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"seniors"	"70"	"93"	"years"	"3"	"132"	"30247603_3_132"
""	"body skin"	"T cells CD4+; T cells CD8+"	"2"	"CD4-positive, alpha-beta T cell; CD8-positive, alpha-beta T cell"	"2"	"CL_0000624"	""	"cell type frequency"	"up"	"none"	"7"	"days"	"time of VZV antigen challenge"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"pre-vaccination vs 7d post-VZV antigen challenge"	"adults (70-93)"	""	""	"30247603"	"2018"	"Fig 3a-c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F3/ "	"-2:1 ratio of female:male"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"seniors"	"70"	"93"	"years"	"4"	"133"	"30247603_4_133"
""	"body skin"	"T cells CD8+ Ki67+"	"1"	"CD8-positive, alpha-beta T cell & pKI-67+"	"1"	"CL_0000625"	"PR:000029630"	"cell type frequency"	"up"	"none"	"7"	"days"	"time of VZV antigen challenge"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"pre-vaccination vs 7d post-VZV antigen challenge"	"adults (70-93)"	""	""	"30247603"	"2018"	"Fig 4b-c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F4/"	"-2:1 ratio of female:male"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"seniors"	"70"	"93"	"years"	"5"	"134"	"30247603_5_134"
""	"body skin"	"T cells CD4+ Tregs Foxp3+"	"1"	"regulatory T cell & FOXP3+"	"1"	"CL_0000815"	"PR_000001350 "	"cell type frequency"	"down"	"none"	"3"	"days"	"time of VZV antigen challenge"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"pre-vaccination vs 3d post-VZV antigen challenge"	"adults (70-93)"	""	""	"30247603"	"2018"	"Fig 4e"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F4/"	"-2:1 ratio of female:male"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"seniors"	"70"	"93"	"years"	"6"	"135"	"30247603_6_135"
""	"body skin"	"T cells CD4+ Tregs Foxp3+"	"1"	"regulatory T cell & FOXP3+"	"1"	"CL_0000815"	"PR_000001350 "	"cell type frequency"	"down"	"none"	"7"	"days"	"time of VZV antigen challenge"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"pre-vaccination vs 7d post-VZV antigen challenge"	"adults (70-93)"	""	""	"30247603"	"2018"	"Fig 4e"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F4/"	"-2:1 ratio of female:male"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"seniors"	"70"	"93"	"years"	"7"	"136"	"30247603_7_136"
""	"peripheral blood mononuclear cell"	"CD3- CD56dim Natural Killer cells"	"1"	"natural killer cell & CD3-, CD56-dim"	"1"	"CL_0000623"	"PR:000001020, PR:000001024"	"cell type frequency"	"up"	"high antibody responders"	"14"	"days"	"time of vaccination (first dose)"	"human immunodeficiency virus 1"	""	"CN54gp140 "	"VO_0004891"	""	"14d vs 0hr"	"adults (18-45)"	"GLA-AF"	""	"29535712"	"2018"	"Fig 4"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834766/figure/F4/"	"-1 intramuscular dose"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834766/"	"adults"	"18"	"45"	"years"	"1"	"137"	"29535712_1_137"
""	"peripheral blood mononuclear cell"	"memory T cells VZV-specific CD4+"	"1"	"CD4-positive, alpha-beta memory T cell & VZV-specific"	"1"	"CL_0000897"	""	"cell type frequency"	"up"	"none"	"30"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"30d vs 0d"	"young adults (25-40)"	""	""	"28607114"	"2017"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"adults"	"25"	"40"	"years"	"1"	"138"	"28607114_1_138"
""	"peripheral blood mononuclear cell"	"memory T cells VZV-specific CD4+"	"1"	"CD4-positive, alpha-beta memory T cell & VZV-specific"	"1"	"CL_0000897"	""	"cell type frequency"	"up"	"none"	"30"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"30d vs 0d"	"senior adults (60-80)"	""	""	"28607114"	"2017"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"seniors"	"60"	"80"	"years"	"2"	"139"	"28607114_2_139"
""	"peripheral blood mononuclear cell"	"memory T cells VZV-specific CD4+"	"1"	"CD4-positive, alpha-beta memory T cell & VZV-specific"	"1"	"CL_0000897"	""	"cell type frequency"	"up"	"none"	"90"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"90d vs 0d"	"young adults (25-40)"	""	""	"28607114"	"2017"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"adults"	"25"	"40"	"years"	"3"	"140"	"28607114_3_140"
""	"peripheral blood mononuclear cell"	"memory T cells VZV-specific CD4+"	"1"	"CD4-positive, alpha-beta memory T cell & VZV-specific"	"1"	"CL_0000897"	""	"cell type frequency"	"up"	"none"	"90"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"90d vs 0d"	"senior adults (60-80)"	""	""	"28607114"	"2017"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"seniors"	"60"	"80"	"years"	"4"	"141"	"28607114_4_141"
""	"peripheral blood mononuclear cell"	"memory T cells VZV-specific CD4+"	"1"	"CD4-positive, alpha-beta memory T cell & VZV-specific"	"1"	"CL_0000897"	""	"cell type frequency"	"up"	"none"	"180"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"180d vs 0d"	"senior adults (60-80)"	""	""	"28607114"	"2017"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"seniors"	"60"	"80"	"years"	"5"	"142"	"28607114_5_142"
""	"peripheral blood mononuclear cell"	"memory T cells VZV-specific CD4+"	"1"	"CD4-positive, alpha-beta memory T cell & VZV-specific"	"1"	"CL_0000897"	""	"cell type frequency"	"up"	"none"	"0"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"young adults vs old adults"	"young adults (25-40), senior adults (60-80)"	""	""	"28607114"	"2017"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"adults, seniors"	"25"	"80"	"years"	"6"	"143"	"28607114_6_143"
""	"peripheral blood mononuclear cell"	"memory T cells VZV-specific CD4+"	"1"	"CD4-positive, alpha-beta memory T cell & VZV-specific"	"1"	"CL_0000897"	""	"cell type frequency"	"down"	"none"	"180"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"young adults vs old adults"	"adults (25-80)"	""	""	"28607114"	"2017"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"adults, seniors"	"25"	"80"	"years"	"7"	"144"	"28607114_7_144"
""	"peripheral blood mononuclear cell"	"memory T cells VZV-specific CD4+ IL2+ BCL2+"	"1"	"CD4-positive, alpha-beta memory T cell & IL2+, BCL2+, VZV-specific"	"1"	"CL_0000897"	"PR:000001379, PR_000002307 "	"cell type frequency"	"up"	"none"	"30"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"30d vs 0d"	"young adults (25-40)"	""	""	"28607114"	"2017"	"Fig 1b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"adults"	"25"	"40"	"years"	"8"	"145"	"28607114_8_145"
""	"peripheral blood mononuclear cell"	"memory T cells VZV-specific CD4+ IL2+ BCL2+"	"1"	"CD4-positive, alpha-beta memory T cell & IL2+, BCL2+, VZV-specific"	"1"	"CL_0000897"	"PR:000001379, PR_000002307 "	"cell type frequency"	"up"	"none"	"30"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"30d vs 0d"	"senior adults (60-80)"	""	""	"28607114"	"2017"	"Fig 1b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"seniors"	"60"	"80"	"years"	"9"	"146"	"28607114_9_146"
""	"peripheral blood mononuclear cell"	"memory T cells VZV-specific CD4+ IL2+ BCL2+"	"1"	"CD4-positive, alpha-beta memory T cell & IL2+, BCL2+, VZV-specific"	"1"	"CL_0000897"	"PR:000001379, PR_000002307 "	"cell type frequency"	"down"	"none"	"180"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"180d vs 0d"	"young adults (25-40)"	""	""	"28607114"	"2017"	"Fig 1b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"adults"	"25"	"40"	"years"	"10"	"147"	"28607114_10_147"
""	"peripheral blood mononuclear cell"	"memory T cells VZV-specific CD4+ IL2+ BCL2+"	"1"	"CD4-positive, alpha-beta memory T cell & IL2+, BCL2+, VZV-specific"	"1"	"CL_0000897"	"PR:000001379, PR_000002307 "	"cell type frequency"	"up"	"none"	"180"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"180d vs 0d"	"senior adults (60-80)"	""	""	"28607114"	"2017"	"Fig 1b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"seniors"	"60"	"80"	"years"	"11"	"148"	"28607114_11_148"
""	"peripheral blood mononuclear cell"	"T cells Dual-function VZV-specific CD8+"	"1"	"CD8-positive, alpha-beta T cell & dual-function, VZV-specific"	"1"	"CL_0000625"	""	"cell type frequency"	"up"	"none"	"7"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"ex-vivo restimulation with live VZV"	"7d vs 0d"	"young adults (25-40)"	""	""	"28607114"	"2017"	"Fig 2b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F2/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"adults"	"25"	"40"	"years"	"12"	"149"	"28607114_12_149"
""	"peripheral blood mononuclear cell"	"VZV-specific CD8+ CD69+ CD57+ cells"	"1"	"CD8-positive, alpha-beta T cell & CD69+, VZV-specific, CD57+"	"1"	"CL_0000625"	"PR:000001343"	"cell type frequency"	"up"	"none"	"0"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"ex-vivo restimulation with live VZV"	"old adults vs young adults"	"adults (25-80)"	""	""	"28607114"	"2017"	"Fig 3a-b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F3/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"adults, seniors"	"25"	"80"	"years"	"13"	"150"	"28607114_13_150"
""	"peripheral blood mononuclear cell"	"VZV-specific CD8+ CD69+ PD1+ cells"	"1"	"CD8-positive, alpha-beta T cell & CD69+, PD-1+, VZV-specific"	"1"	"CL_0000625"	"PR:000001343, PR:000001919"	"cell type frequency"	"up"	"none"	"0"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"ex-vivo restimulation with live VZV"	"old adults vs young adults"	"adults (25-80)"	""	""	"28607114"	"2017"	"Fig 3a-b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F3/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"adults, seniors"	"25"	"80"	"years"	"14"	"151"	"28607114_14_151"
""	"peripheral blood mononuclear cell"	"VZV-specific CD8+ CD69+ CD57+ cells"	"1"	"CD8-positive, alpha-beta T cell & CD69+, VZV-specific, CD57+"	"1"	"CL_0000625"	"PR:000001343"	"cell type frequency"	"up"	"none"	"7"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"ex-vivo restimulation with live VZV"	"old adults vs young adults"	"adults (25-80)"	""	""	"28607114"	"2017"	"Fig 3b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F3/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"adults, seniors"	"25"	"80"	"years"	"15"	"152"	"28607114_15_152"
""	"peripheral blood mononuclear cell"	"VZV-specific CD8+ CD69+ CD57+ cells"	"1"	"CD8-positive, alpha-beta T cell & CD69+, VZV-specific, CD57+"	"1"	"CL_0000625"	"PR:000001343"	"cell type frequency"	"up"	"none"	"30"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"ex-vivo restimulation with live VZV"	"old adults vs young adults"	"adults (25-80)"	""	""	"28607114"	"2017"	"Fig 3b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F3/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"adults, seniors"	"25"	"80"	"years"	"16"	"153"	"28607114_16_153"
""	"peripheral blood mononuclear cell"	"VZV-specific CD4+ CD69+ CD57+ PD1+ cells"	"1"	"CD4-positive, alpha-beta T cell & CD69+, PD-1+, CD57+, VZV-specific"	"1"	"CL_0000624"	"PR:000001343, PR:000001919"	"cell type frequency"	"positive"	"older adults"	"30"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"ex-vivo restimulation with live VZV"	"30d vs 0d, significantly negatively correlated with gain in VZV-specific RCF post-vaccination"	"senior adults (60-80)"	""	""	"28607114"	"2017"	"Fig 4"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F4/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"seniors"	"60"	"80"	"years"	"17"	"154"	"28607114_17_154"
""	"peripheral blood mononuclear cell"	"cytotoxic T lymphocytes VZV-specific CD8+ IFNg+ CD107a+"	"1"	"CD8-positive, alpha-beta cytotoxic T cell & CD107a+, IFNg+, VZV-specific"	"1"	"CL_0000794"	"PR:000002060, PR:000000017"	"cell type frequency"	"positive"	"older adults"	"7"	"days"	"time of vaccination (first dose)"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"ex-vivo restimulation with live VZV"	"7d vs 0d, significantly correlated with decrease in VZV-specific CD8+CD69+CD57+PD1+"	"senior adults (60-80)"	""	""	"28607114"	"2017"	"Fig 4"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F4/"	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"seniors"	"60"	"80"	"years"	"18"	"155"	"28607114_18_155"
""	"blood"	"neutrophil; monocyte"	"2"	"neutrophil; monocyte"	"2"	"CL_0000775"	""	"cell type frequency"	"up"	"none"	"1"	"day"	"time of vaccination (first dose)"	"influenza A virus (A/Indonesia/5/2005(H5N1))"	"2005mv"	"inactivated monovalent influenza A/Indonesia/05/2005 H5N1 split-virus vaccine"	"VO_0004903"	""	"1d vs 0d"	"adults (18-49)"	"AS03 (VO_0001320)"	""	"28099485"	"2017"	"Fig A212-213 and Tables A161-A162 in S2 Text"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242433/#pone.0167488.s012"	"-taken subcutaneous"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242433/"	"adults"	"18"	"49"	"years"	"1"	"156"	"28099485_1_156"
""	"blood"	"monocyte; dendritic cell"	"2"	"monocyte; dendritic cell"	"2"	"CL_0000576"	""	"cell type frequency"	"up"	"none"	"3"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/Indonesia/5/2005(H5N1))"	"2005mv"	"inactivated monovalent influenza A/Indonesia/05/2005 H5N1 split-virus vaccine"	"VO_0004903"	""	"3d vs 0d"	"adults (18-49)"	"AS03 (VO_0001320)"	""	"28099485"	"2017"	"Fig A212-213 and Tables A161-A162 in S2 Text"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242433/#pone.0167488.s012"	"-taken subcutaneous"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242433/"	"adults"	"18"	"49"	"years"	"2"	"157"	"28099485_2_157"
""	"blood"	"CD16+ HLA-DR++ CD14+ monocytes; CD69+ CD19+ B-cells; CXCR4+ CD8+ T-cells; CD69+ CD8+ T-cells; CCR5+ CD4+ T-cells; CD54+ CD4+ T-cells; CD69+ CD4+ T-cells"	"7"	"CD14-positive, CD16-positive monocyte & HLA-DR++; B cell & CD19+, CD69+; CD8-positive, alpha-beta T cell & CXCR4+; CD8-positive, alpha-beta T cell & CD69+; CD4-positive, alpha-beta T cell & CCR5+; CD4-positive, alpha-beta T cell & CD54+; CD4-positive, alpha-beta T cell & CD69+"	"7"	"CL_0002397"	""	"cell type frequency"	"up"	"none"	"3"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2009mv"	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO_0000160"	""	"3d vs 0d"	"adults (21-51)"	""	""	"28549970"	"2017"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"1"	"158"	"28549970_1_158"
""	"blood"	"CD16+ CD56+ CD3- Natural Killer cells; CD16+ CD56+ CD3+ Natural Killer cells; HLA-DR+ CD4+ T-cells; HLA-DR+ CD8+ T-cells"	"4"	"natural killer cell & CD56+, CD16+; natural killer cell & CD16+, CD56+, CD3+; CD4-positive, alpha-beta T cell & HLA-DR+; CD8-positive, alpha-beta T cell & HLA-DR+"	"4"	"CL_0000623"	"PR_000001024, PR_000001483"	"cell type frequency"	"down"	"none"	"3"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2009mv"	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO_0000160"	""	"3d vs 0d"	"adults (21-51)"	""	""	"28549970"	"2017"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"2"	"159"	"28549970_2_159"
""	"blood"	"CD69+ CD19+ B-cells; CCR3+ CD4+ T-cells; CCR5+ CD4+ T-cells; CXCR4+ CD8+ T-cells"	"4"	"B cell & CD19+, CD69+; CD4-positive, alpha-beta T cell & CCR3+; CD4-positive, alpha-beta T cell & CCR5+; CD8-positive, alpha-beta T cell & CXCR4+"	"4"	"CL_0000236"	"PR_000001002, PR:000001343"	"cell type frequency"	"up"	"none"	"7"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2009mv"	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO_0000160"	""	"7d vs 0d"	"adults (21-51)"	""	""	"28549970"	"2017"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"3"	"160"	"28549970_3_160"
""	"blood"	"HLA-DR++ CD16+ CD14+ monocytes; CCR2+ CD14+ monocytes; CD16+ CD56+ CD3+ Natural Killer cells; CD69+ CD4+ T-cells; CD25high CD4+ T-cells; HLA-DR+ CD4+ T-cells; HLA-DR+ CD8+ T-cells; CD38+ CD8+ T-cells"	"8"	"CD14-positive, CD16-positive monocyte & HLA-DR++; CD14-positive monocyte & CCR2+; natural killer cell & CD16+, CD56+, CD3+; CD4-positive, alpha-beta T cell & CD69+; CD4-positive, CD25-positive, alpha-beta regulatory T cell & CD25-hi; CD4-positive, alpha-beta T cell & HLA-DR+; CD8-positive, alpha-beta T cell & HLA-DR+; CD8-positive, alpha-beta T cell & CD38+"	"8"	"CL_0002397"	""	"cell type frequency"	"down"	"none"	"7"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2009mv"	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO_0000160"	""	"7d vs 0d"	"adults (21-51)"	""	""	"28549970"	"2017"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"4"	"161"	"28549970_4_161"
""	"blood"	"HLA-DR++ CD16+ CD14+ monocytes; CD25+ CD4+ T-cells; CCR3+ CD4+ T-cells; CCR5+ CD4+ T-cells; CXCR3+ CD4+ T-cells; CD69+ CD8+ T-cells; CD25+ CD8+ T-cells; CCR3+ CD8+ T-cells; CD5+ CD19+ B-cells; CD69+ CD19+ B-cells"	"10"	"CD14-positive, CD16-positive monocyte & HLA-DR++; CD4-positive, CD25-positive, alpha-beta regulatory T cell; CD4-positive, alpha-beta T cell & CCR3+; CD4-positive, alpha-beta T cell & CCR5+; CD4-positive, alpha-beta T cell & CXCR3+; CD8-positive, alpha-beta T cell & CD69+; CD8-positive, CD25-positive, alpha-beta regulatory T cell; CD8-positive, alpha-beta T cell & CCR3+; B cell, CD19-positive & CD5+; B cell & CD19+, CD69+"	"10"	"CL_0002397"	""	"cell type frequency"	"up"	"none"	"30"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2009mv"	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO_0000160"	""	"30d vs 0d"	"adults (21-51)"	""	""	"28549970"	"2017"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"5"	"162"	"28549970_5_162"
""	"blood"	"CD54+ CD4+ T-cells; CXCR4+ CD4+ T-cells; CD38+ CD8+ T-cells; CCR5+ CD14+ monocytes"	"4"	"CD4-positive, alpha-beta T cell & CD54+; CD4-positive, alpha-beta T cell & CXCR4+; CD8-positive, alpha-beta T cell & CD38+; CD14-positive monocyte & CCR5+"	"4"	"CL_0000624"	"PR:000001467"	"cell type frequency"	"down"	"none"	"30"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2009mv"	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO_0000160"	""	"30d vs 0d"	"adults (21-51)"	""	""	"28549970"	"2017"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"6"	"163"	"28549970_6_163"
""	"blood"	"CD64+ CD14+ monocytes; CCR2+ CD14+ monocytes; CCR5+ CD14+ monocytes; CD14+ monocytes; CD19+ B-cells; CD5+ CD19+ B-cells; CD69+ CD4+ T-cells; HLA-DR+ CD4+ T-cells; CCR3+ CD4+ T-cells; CCR5+ CD4+ T-cells; CXCR4+ CD4+ T-cells; HLA-DR+ CD8+ T-cells; CXCR3+ CD8+ T-cells; CXCR4+ CD8+ T-cells"	"14"	"CD14-positive monocyte & CD64+; CD14-positive monocyte & CCR2+; CD14-positive monocyte & CCR5+; CD14-positive monocyte; B cell & CD19+; B cell, CD19-positive & CD5+; CD4-positive, alpha-beta T cell & CD69+; CD4-positive, alpha-beta T cell & HLA-DR+; CD4-positive, alpha-beta T cell & CCR3+; CD4-positive, alpha-beta T cell & CCR5+; CD4-positive, alpha-beta T cell & CXCR4+; CD8-positive, alpha-beta T cell & HLA-DR+; CD8-positive, alpha-beta T cell & CXCR3+; CD8-positive, alpha-beta T cell & CXCR4+"	"14"	"CL_0001054"	""	"cell type frequency"	"up"	"none"	"1"	"day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	""	"Pandemrix"	"VO_0000410"	""	"1d vs 0d"	"adults (21-51)"	"AS03 (VO_0001320)"	""	"28549970"	"2017"	"Fig 2: black bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"7"	"164"	"28549970_7_164"
""	"blood"	"HLA-DR+ CD8+ T-cells; CD69+ CD8+ T-cells; CXCR4+ CD8+ T-cells; CD19+ CD69+ B-cells; HLA-DR+ CD4+ T-cells; CD69+ CD4+ T-cells; CXCR4+ CD4+ T-cells; CCR3+ CD4+ T-cells; CD16+ CD56+ CD3+ Natural Killer cells"	"9"	"CD8-positive, alpha-beta T cell & HLA-DR+; CD8-positive, alpha-beta T cell & CD69+; CD8-positive, alpha-beta T cell & CXCR4+; B cell & CD19+, CD69+; CD4-positive, alpha-beta T cell & HLA-DR+; CD4-positive, alpha-beta T cell & CD69+; CD4-positive, alpha-beta T cell & CXCR4+; CD4-positive, alpha-beta T cell & CCR3+; natural killer cell & CD16+, CD56+, CD3+"	"9"	"CL_0000625"	""	"cell type frequency"	"down"	"none"	"1"	"day"	"time of vaccination (first dose)"	"influenza A virus (H1N1)"	""	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO_0000160"	""	"1d vs 0d"	"adults (21-51)"	""	""	"28549970"	"2017"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"8"	"165"	"28549970_8_165"
""	"blood"	"HLA-DR++ CD16+ CD14+ monocytes; CD64+ CD14+ monocytes; CD69+ CD4+ T-cells; CD54+ CD4+ T-cells; CCR5+ CD4+ T-cells; CXCR3+ CD4+ T-cells; CD69+ CD8+ T-cells; CD25+ CD8+ T-cells; CCR3+ CD8+ T-cells"	"9"	"CD14-positive, CD16-positive monocyte & HLA-DR++; CD14-positive monocyte & CD64+; CD4-positive, alpha-beta T cell & CD69+; CD4-positive, alpha-beta T cell & CD54+; CD4-positive, alpha-beta T cell & CCR5+; CD4-positive, alpha-beta T cell & CXCR3+; CD8-positive, alpha-beta T cell & CD69+; CD8-positive, CD25-positive, alpha-beta regulatory T cell; CD8-positive, alpha-beta T cell & CCR3+"	"9"	"CL_0002397"	""	"cell type frequency"	"up"	"none"	"3"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	""	"Pandemrix"	"VO_0000410"	""	"3d vs 0d"	"adults (21-51)"	"AS03 (VO_0001320)"	""	"28549970"	"2017"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"9"	"166"	"28549970_9_166"
""	"blood"	"CD69+ CD19+ B-cells"	"1"	"B cell & CD19+, CD69+"	"1"	"CL_0000236"	"PR_000001002, PR:000001343"	"cell type frequency"	"down"	"none"	"3"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	""	"Pandemrix"	"VO_0000410"	""	"3d vs 0d"	"adults (21-51)"	"AS03 (VO_0001320)"	""	"28549970"	"2017"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"10"	"167"	"28549970_10_167"
""	"blood"	"HLA-DR++ CD16+ CD14+ monocytes; CCR2+ CD14+ monocytes; CD69+ CD4+ T-cells; HLA-DR+ CD4+ T-cells; CXCR3+ CD4+ T-cells; CD69+ CD8+ T-cells; CD25+ CD8+ T-cells; HLA-DR+ CD8+ T-cells; CCR3+ CD8+ T-cells"	"9"	"CD14-positive, CD16-positive monocyte & HLA-DR++; CD14-positive monocyte & CCR2+; CD4-positive, alpha-beta T cell & CD69+; CD4-positive, alpha-beta T cell & HLA-DR+; CD4-positive, alpha-beta T cell & CXCR3+; CD8-positive, alpha-beta T cell & CD69+; CD8-positive, CD25-positive, alpha-beta regulatory T cell; CD8-positive, alpha-beta T cell & HLA-DR+; CD8-positive, alpha-beta T cell & CCR3+"	"9"	"CL_0002397"	""	"cell type frequency"	"up"	"none"	"7"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	""	"Pandemrix"	"VO_0000410"	""	"7d vs 0d"	"adults (21-51)"	"AS03 (VO_0001320)"	""	"28549970"	"2017"	"Fig 2: black bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"11"	"168"	"28549970_11_168"
""	"blood"	"CD16+ CD56+ CD3+ Natural Killer cells"	"1"	"natural killer cell & CD16+, CD56+, CD3+"	"1"	"CL_0000623"	"PR_000001483, PR_000001024, PR:000001020 "	"cell type frequency"	"down"	"none"	"7"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	""	"Pandemrix"	"VO_0000410"	""	"7d vs 0d"	"adults (21-51)"	"AS03 (VO_0001320)"	""	"28549970"	"2017"	"Fig 2: black bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"12"	"169"	"28549970_12_169"
""	"blood"	"HLA-DR++ CD16+ CD14+ monocytes; CD64+ CD14+ monocytes; CCR2+ CD14+ monocytes; CD16+ CD56+ CD3- Natural Killer cells; CXCR4+ CD4+ T-cells; CXCR4+ CD8+ T-cells; CD32+ CD19+ B-cells; CD69+ CD8+ T-cells; CD25+ CD8+ T-cells; CCR3+ CD8+ T-cells"	"10"	"CD14-positive, CD16-positive monocyte & HLA-DR++; CD14-positive monocyte & CD64+; CD14-positive monocyte & CCR2+; natural killer cell & CD56+, CD16+; CD4-positive, alpha-beta T cell & CXCR4+; CD8-positive, alpha-beta T cell & CXCR4+; B cell & CD32+, CD19+; CD8-positive, alpha-beta T cell & CD69+; CD8-positive, CD25-positive, alpha-beta regulatory T cell; CD8-positive, alpha-beta T cell & CCR3+"	"10"	"CL_0002397"	""	"cell type frequency"	"up"	"none"	"30"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	""	"Pandemrix"	"VO_0000410"	""	"30d vs 0d"	"adults (21-51)"	"AS03 (VO_0001320)"	""	"28549970"	"2017"	"Fig 2: black bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"13"	"170"	"28549970_13_170"
""	"blood"	"total CD14+ monocytes; CCR5+ CD14+ monocytes; CD16+ CD56+ CD3+ Natural Killer cells; CD54+ CD4+ T-cells; CCR3+ CD4+ T-cells; CXCR4+ CD4+ T-cells; CD54+ CD8+ T-cells"	"7"	"CD14-positive monocyte & (total); CD14-positive monocyte & CCR5+; natural killer cell & CD16+, CD56+, CD3+; CD4-positive, alpha-beta T cell & CD54+; CD4-positive, alpha-beta T cell & CCR3+; CD4-positive, alpha-beta T cell & CXCR4+; CD8-positive, alpha-beta T cell & CD54+"	"7"	"CL_0001054"	""	"cell type frequency"	"down"	"none"	"30"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	""	"Pandemrix"	"VO_0000410"	""	"30d vs 0d"	"adults (21-51)"	"AS03 (VO_0001320)"	""	"28549970"	"2017"	"Fig 2: black bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	"-taken subcutaneous"	""	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"adults"	"21"	"51"	"years"	"14"	"171"	"28549970_14_171"
""	"peripheral blood mononuclear cell"	"plasma cells"	"1"	"plasma cell"	"1"	"CL_0000786"	""	"cell type frequency"	"up"	"none"	"1"	"day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"1d vs -7d"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Fig 1C-D, Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F1/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"1"	"172"	"26726811_1_172"
""	"peripheral blood mononuclear cell"	"monocytes; CD16+ inflammatory monocytes"	"2"	"monocyte; monocyte & CD16-positive, inflammatory"	"2"	"CL_0000576"	""	"cell type frequency"	"up"	"none"	"1"	"day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"1d  vs  prevax"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Fig 1C-D, Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F1/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"2"	"173"	"26726811_2_173"
""	"peripheral blood mononuclear cell"	"all T-cells; gamma-delta cells; CD8+ T cells; CD4+ T cells"	"4"	"T cell; gamma-delta T cell; CD8-positive, alpha-beta T cell; CD4-positive, alpha-beta T cell"	"4"	"CL_0000084"	""	"cell type frequency"	"down"	"none"	"1"	"day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"1d  vs  prevax"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Fig 1C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F1/"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"3"	"174"	"26726811_3_174"
""	"peripheral blood mononuclear cell"	"plasma cell"	"1"	"plasma cell"	"1"	"CL_0000786"	""	"cell type frequency"	"up"	"none"	"7"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"7d  vs  prevax"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Fig 1D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F1/"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"4"	"175"	"26726811_4_175"
""	"peripheral blood mononuclear cell"	"CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell"	"2"	"gamma-delta T cell & CD69+; natural killer cell & CD69+"	"2"	"CL_0000798"	"PR:000001343"	"cell type frequency"	"up"	"none"	"-7"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"non-responders vs responders"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 6D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"5"	"176"	"26726811_5_176"
""	"peripheral blood mononuclear cell"	"CXCR3+ CD8+ IFN-gamma producing T-cells"	"1"	"CD8-positive, alpha-beta T cell & IFNG+, CXCR3+"	"1"	"CL_0000625"	"PR:000000017"	"cell type frequency"	"down"	"<35yr old"	"1"	"day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"1d vs 0d"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 5B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"6"	"177"	"26726811_6_177"
""	"peripheral blood mononuclear cell"	"CXCR3+ CD8+ IFN-gamma producing T-cells"	"1"	"CD8-positive, alpha-beta T cell & IFNG+, CXCR3+"	"1"	"CL_0000625"	"PR:000000017"	"cell type frequency"	"down"	"<35yr old"	"1"	"day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"1d-(-7d)"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 5B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"7"	"178"	"26726811_7_178"
""	"peripheral blood mononuclear cell"	"CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell"	"2"	"gamma-delta T cell & CD69+; natural killer cell & CD69+"	"2"	"CL_0000798"	"PR:000001343"	"cell type frequency"	"up"	"none"	"0"	"day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"non-responders vs responders"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 6D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"8"	"179"	"26726811_8_179"
""	"peripheral blood mononuclear cell"	"CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell"	"2"	"gamma-delta T cell & CD69+; natural killer cell & CD69+"	"2"	"CL_0000798"	"PR:000001343"	"cell type frequency"	"up"	"none"	"1"	"day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"non-responders vs responders"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 6D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"9"	"180"	"26726811_9_180"
""	"peripheral blood mononuclear cell"	"CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell"	"2"	"gamma-delta T cell & CD69+; natural killer cell & CD69+"	"2"	"CL_0000798"	"PR:000001343"	"cell type frequency"	"up"	"none"	"7"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"non-responders vs responders"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 6D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"10"	"181"	"26726811_10_181"
""	"peripheral blood mononuclear cell"	"CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell"	"2"	"gamma-delta T cell & CD69+; natural killer cell & CD69+"	"2"	"CL_0000798"	"PR:000001343"	"cell type frequency"	"up"	"none"	"14"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"non-responders vs responders"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 6D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"11"	"182"	"26726811_11_182"
""	"peripheral blood mononuclear cell"	"CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell"	"2"	"gamma-delta T cell & CD69+; natural killer cell & CD69+"	"2"	"CL_0000798"	"PR:000001343"	"cell type frequency"	"up"	"none"	"63"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"1d vs -7d"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 6D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"12"	"183"	"26726811_12_183"
""	"peripheral blood mononuclear cell"	"CD38+ CD8+ T-cells"	"1"	"CD8-positive, alpha-beta T cell & CD38+"	"1"	"CL_0000625"	"PR:000001408"	"cell type frequency"	"down"	"none"	"0"	"day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"-7d vs 0d, negatively correlated with age"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"13"	"184"	"26726811_13_184"
""	"peripheral blood mononuclear cell"	"CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells"	"2"	"central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+; central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+"	"2"	"CL_0000904"	"PR_000001017, PR_000001203"	"cell type frequency"	"up"	"none"	"-7"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"<35yr old vs >35yr old"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"14"	"185"	"26726811_14_185"
""	"peripheral blood mononuclear cell"	"CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells"	"2"	"central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+; central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+"	"2"	"CL_0000904"	"PR_000001017, PR_000001203"	"cell type frequency"	"up"	"none"	"0"	"day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"<35yr old vs >35yr old"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"15"	"186"	"26726811_15_186"
""	"peripheral blood mononuclear cell"	"CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells"	"2"	"central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+; central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+"	"2"	"CL_0000904"	"PR_000001017, PR_000001203"	"cell type frequency"	"up"	"none"	"1"	"day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"<35yr old vs >35yr old"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"16"	"187"	"26726811_16_187"
""	"peripheral blood mononuclear cell"	"CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells"	"2"	"central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+; central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+"	"2"	"CL_0000904"	"PR_000001017, PR_000001203"	"cell type frequency"	"up"	"none"	"7"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"<35yr old vs >35yr old"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"17"	"188"	"26726811_17_188"
""	"peripheral blood mononuclear cell"	"CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells"	"2"	"central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+; central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+"	"2"	"CL_0000904"	"PR_000001017, PR_000001203"	"cell type frequency"	"up"	"none"	"14"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"<35yr old vs >35yr old"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"18"	"189"	"26726811_18_189"
""	"peripheral blood mononuclear cell"	"CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells"	"2"	"central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+; central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+"	"2"	"CL_0000904"	"PR_000001017, PR_000001203"	"cell type frequency"	"up"	"none"	"63"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix (A/California/7/09 (H1N1))"	"VO_0000410"	""	"<35yr old vs >35yr old"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"19"	"190"	"26726811_19_190"
""	"peripheral blood mononuclear cell"	"CD8+ CXCR3+ alpha-beta regulatory T cell"	"1"	"CD8-positive, CXCR3-positive, alpha-beta regulatory T cell"	"1"	"CL_0001041"	""	"cell type frequency"	"down"	"<35yr old"	"1"	"day"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix"	"VO_0000410"	""	"1d vs 0d"	"adults (18-35)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Supp Fig 5b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults"	"18"	"35"	"years"	"20"	"191"	"26726811_20_191"
""	"peripheral blood mononuclear cell"	"CD27+ CD38hi plasmablasts"	"1"	"plasmablast & CD27+, CD38-hi"	"1"	"CL_0000980"	"PR:000001963, PR:000001408"	"cell type frequency"	"up"	"none"	"7"	"days"	"time of vaccination (first dose)"	"influenza A virus (A/California/7/2009(H1N1))"	"2010"	"Pandemrix"	"VO_0000410"	""	"responder vs non-responder"	"adults (18-64)"	"AS03 (GSK)"	""	"26726811"	"2016"	"Fig 4d"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F4/"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"adults, seniors"	"18"	"64"	"years"	"21"	"192"	"26726811_21_192"
